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7Abstract
T lymphocytes develop in the thymus through multiple stages (DN, DP and SP) during
which their survival and lineage are determined. During thymocyte maturation, T-cell
Receptor (TCR) signaling induces important downstream mediators of
differentiation. ThPOK (T-helper inducing POZ-Kruppel factor) has been identified
as a master regulator of lineage commitment at the CD4/CD8 branch point, and is
selectively induced in class II-restricted thymocytes, suggesting that it is upregulated
by strong TCR signals. In order to identify upstream signaling pathways responsible
for ThPOK induction, we mapped key transcriptional control elements at the ThPOK
locus. These studies show that a dual silencer/enhancer element is primarily
responsible for selective induction of ThPOK. We are currently attempting to identify
key factors that bind to and regulate activity of this element during thymocyte
development. Given that γδ lineage commitment, like CD4 commitment, may be
decided by relative TCR signal strength, it is possible that the same downstream
effectors may be involved in both processes. However, the potential role of ThPOK in
γδ commitment has not yet been explored. By carrying out in vitro stimulation of γδ
thymocytes with anti-TCR antibody and varying ligand affinity for the transgenic
KN6 γδTCR in vivo, we have now established that ThPOK induction in γδTCR+
thymocytes is controlled by TCR signaling and specifically requires a strong/ high
affinity TCR ligand. Strikingly, ThPOK deficient mice show a severe reduction in
mature γδ thymocytes as well as altered V region usage in γδ thymocytes, showing that
ThPOK is important for maturation/selection of γδ cells. ThPOK is particularly
important for development of a subset of γδ thymocytes that express Vγ1.1 and  the
NK1.1 surface marker, which has been previously referred to as NKTγδ cells and
appears to be enriched for self-reactive specificities. Conversely, in mice that express
ThPOK constitutively, the proportion of mature γδ thymocytes is greatly increased, as
is the proportion of Vγ1.1+ thymocytes. These results demonstrate a new role for
ThPOK in development of γδ thymocytes. Future work will distinguish whether
ThPOK is important for differentiation, proliferation and our lineage commitment of
the γδ subset.
8
9I. Background and Research Summary
Organisms are under continual challenge by foreign materials, including chemicals,
bacteria and viruses. The innate immune system provides the first rapid line of defense
against invaders in higher vertebrates, whereas adaptive (acquired) immunity, which is
more efficient and highly specific, provides long-lasting protection, as exemplified by
immunological memory. Two major players perform the key roles roles in the adaptive
immune response, i.e. B lymphocytes which secrete antibodies (humoral immunity), and T
lymphocytes which directly interact with target cells (cell-mediate immunity). T cells are
further divided into two major functionally distinct lineages, characterized by different
expression patterns of the CD4 and CD8 surface markers. CD4+ T cell promote the
functional response of B cells and CD8+ T cells, whereas CD8+ cytotoxic T cell are
directly responsible for killing pathogen-infected cells. Here, we examine how T cells
diverge into alternate lineage during thymocyte development and in particular the role of
the transcription factor ThPOK.
1. Thymic Development
Hematopoietic stem cells present in the fetal liver and adult bone marrow, are the
precursors of all mature blood cells. Stem cells give rise to the common lymphoid
progenitor cell (CLP), which in turn can develop into mature B or following migration to
the thymus into T lymphocytes(1, 2). The thymus is also an important orgen for
development of natural killer (NK) cells, which play an important role in innate immunity.
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The thymus is the primary organ for producing T cells. Located in the upper thorax, it
consists of two major cell types, the stromal and T lymphoid compartments(3). The stromal
cells include epithelial cells, macrophages, and dendritic cells and are organized into
discrete structural and functional regions. Progenitor lymphocytes arrive in the thymus
where they receive signals, mostly from stromal cells, via their surface Notch receptors.
Notch signals instruct the precursor cells to commit to the T rather than B cell lineage. The
thymus consists of an outer region, called the cortex and an inner medulla. Initially,
progenitors from the bone marrow enter at the middle of the cortex and medulla and
migrate to the outer cortex and then back to the medulla as development progresses(4).
Accordingly, most T cell development takes place in the cortex, and only mature single-
positive thymocytes are seen in the medulla(5), (6) (Figure 1). Immature CD4-CD8-,
double negative (DN), thymocytes proliferate vigorously and give rise to all subsequent
thymocytes populations. The cortical stroma is composed of epithelial cells expressing both
major histocompatibility complex (MHC) class II and MHC class I molecules on their
surface (7, 8).. Contact between the MHC molecules and the receptors of T cells plays a
crucial role in positive selection. Antigen recognition by the T cell receptor (TCR) differs
significantly from antigen recognition by the B cell receptor (BCR). In particular, while the
BCR can bind directly to foreign antigens, the TCR recognizes foreign antigens only as
small proteolytic fragments bound to self MHC class I or II antigens expressed on antigen
presenting cells (APCs). The fact that T cells recognize antigen only in the context of self
MHC products, and will not recognize the same antigens in the context of non-self MHC
products expressed by another individual, is called MHC restriction.
11
Development of T cells involves multiple stages, distinguished by stage-specific expresson
of CD4 and CD8 surface markers. The most immature precursor cells entering the thymus
from the bone marrow lack expression of surface TCR as well as both CD4 and CD8
molecules.  The majority of DN cells expresses neither the αβ nor the γδ cells (so-called
triple negative cells), and can be further split into stages according to expression of the
CD44 and CD25 molecules. In order of maturation, they are divided into CD44+CD25-
(DN1), CD44+CD25+ (DN2), CD44-CD25+ (DN3), and CD44-CD25- (DN4) subsets,
respectively (Figure 2). The TCRβ gene undergoes rearrangement at the DN3 stage and is
expressed at low levels together with the invariant preTα chain. The DN subset also
contains more mature cell types that already express either γδTCR or αβTCR on the cell
surface. γδ T cells seem to differ functionally from most αβ cells, in that they usually do
not recognize MHC molecules and exhibit more rapid cytokine response upon antigenic
stimulation.  They are thought to function at the interface between innate and adaptive
immunity. In the mouse, there are various populations of γδ T cells in peripheral tissues
including skin, gut and uterus. Each tissue has its own specific subset of γδ T cells, based
on which variable (V) gene is used to generate the TCR.
Double positive (DP, CD4+CD8+) cells make up the vast majority of thymocytes (>80%).
They have rearranged TCR-α and -β genes, and most express at least low levels of αβTCR
complex on the surface. DP thymocytes undergo selection based on the ability of their
clonotypic TCR molecules to recognize self MHC molecules. Most DP thymocytes
undergo negative selection by apoptosis or death by neglect, while a small minority with
appropriate affinity for thymic MHC antigens undergoes positive selection and progression
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to the single positive (SP, CD4+CD8- and CD4-CD8+) stages. The ratio of SP CD4: CD8
thymocytes is usually 3:1, but shows some genetic variation between different mouse
strains. Between the DP and SP stages there is an intermediate stage that expresses high
levels of CD4 but low CD8, called the CD4+8lo subset. It is believed that commitment to
the CD4 or CD8 lineages occurs at this stage. Fully mature SP thymocytes are
characterized by downmodulation of the activation molecule CD69. The mature cells then
migrate to the periphery (Figure 2).
13
DN1
DN2
DN3 DN4 DP
CD4 CD8
Corte
x
Cortico-Medullary Junction
Medulla
Blood
Vessel
14
Figure 1. Movement of developing thymocytes through the adult thymus. Common
lymphoid progenitor cells (CLPs) enter the thymus through blood vessels in the medulla or
cortico–medullary junction where they undergo progressive differentiation from double-
negative (DN) to double-positive (DP) to single-positive (SP) thymocytes as they move
through the distinct microenvironments of the thymus. The DN1 stage is situated close to
the site of entry deep within the cortex. The DN2 population moves across the cortex and
into the subcapsular zone. The DN3 population stays within and accumulates in the
subcapsula where transition to the DN4 stage happens. Progression to the DP stage, through
an immature CD8+ SP (ISP) cell intermediate, is accompanied by a reversal in direction of
migration of the cells back across the cortex towards the medulla. CD4+ or CD8+ SP T
cells are found in the medulla.
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Figure 2. T cell development in the thymus. Development and the lineage commitment of
T cell in the thymus is shown. Two major lineage choices occurred in DN and DP stages
for γδ-/αβ-TCR and SP CD4+/CD8+, respectively. ThPOK is reported as a key player in
lineage commitment of SP CD4.  We here hypothesized and demonstrated that ThPOK has
a similar role in γδ lineage T cell. (B) FACScan analysis showing all populations of
thymocytes and pathway of SP CD4 and SP CD8 development. (C) PBL analysis shows wt,
HD-/- and ThPOK transgenic mice.
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2. Role of TCR rearrangement in T cell development.
TCR gene rearrangement and expression are critical factors in driving development and
lineage choice by immature thymocytes. Rearrangements of the different TCR genes are
developmentally regulated.
The first complete TCR rearrangements rearrangements of the TCR-β, γ, δ genes are
detected at the DN3 stage (9). If a functional γδ receptor is assembled at the surface, the
cell may proceed along the pathway to become a mature γδ cells (10). There is evidence
that development to the gd lineage requires not only expression of the gdTCR but also its
engagement by intrathymic ligands. On the other hand, expression of a functional β chain is
necessary for development to the ab lineage. TCRb dimerizes with the  invariant pTa chain
to from the preTCR (11). The appearance of this preTCR complex at the cell surface halts
TCRβ gene rearrangement and allows differentiation along the αβ lineage pathway.
Although the preTCR seems to mediate an important developmental signal for progression
to the ab lineage, this apparently does not require its engagement by intrathymic ligands. At
the DP stage, rearrangements at the TCR-α locus start to be detectable. V-J rearrangement
at the TCR-α locus results in deletion of the TCR-δ gene segments, so that once both α loci
have rearranged, the thymocyte is irreversibly confirmed in its decision to become an αβ
cell. Onset and termination of TCR gene rearrangement during differentiation is controlled
by the availability of RAG proteins.
αβTCR cells can recognize an antigen only when bound to MHC molecules on the surface
of an antigen-presenting cell. The phenomenon of MHC restriction refers to the fact that
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mature T cells only recognize their own “self” MHC, not different allelic forms expressed
by unrelated individuals. Almost all T cells that express the αβ TCR also express either the
CD4 or CD8 coreceptors, which bind to constant portions of the MHC class II or I
molecules, respectively, and play a critical role in facilitating the TCR/ligand interaction
and TCR signaling. Fully matured αβ thymocytes migrate to the secondary lymphoid
organs where they encounter foreign antigens. Naïve αβ T cells that have not yet been
antigenically challenged recirculate from the blood stream to central lymphatic vessel via
the spleen, lymph nodes, Peyer’s patches until they encounter foreign antigen and become
effector cells. Effector cells respond to infections by activating the production of antibodies
and inducing death of infected, damaged or dysfunctional cells.
γδ T cells represent a distinct T cell subset(12, 13), that are less common in the classical
lymphoid sites, i.e. spleen, blood and lymph nodes (1-5% of total T cells) (14), but are
predominant in various epithelial tissues, comprising as much as 50%  of the T cells found
in those areas (15), (16), (17).  γδ T cells unlike ab cells, usually do not recognize processed
foreign antigens in the context of self MHC, but seem to recognize a wide variety of intact
antigens directly, including non-classical MHC molecules, HSA and lipids. Their ability to
recognize antigen directly, without the processing and presentation, is consistent with a role
as front-line defense against pathogens(18), (13, 19), (20, 21), (22).
Finally, a number of rare ab T cell subsets are recognized, which exhibit distinct antigen
recognition and functional properties compared to “conventional” T cells. So-called NKT
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cells comprise a population of αβ CD4+ T cells that are not restricted to MHC class-II
molecules, but rather recognize nonclassical MHC class I molecules such as CD1. A
proportion of these cells express surface marker characteristic of conventional natural killer
cells, including NK1.1, but differ from NK cells in also expressing the abTCR. NKT cells
are characterized by rapid cytokine production in response to antigenic challenge and may
play an important role in the first line of defense against foreign pathogens.
3. TCR Signaling Model : γδ/αβ and CD4/CD8
The mechanism by which developing T cells decide to adopt the αβ or γδ lineages has been
a subject of considerable interest. A crucial issue is whether pre-TCR and γδTCR-mediated
signals control αβ versus γδ T cell lineage choice directly (11, 23, 24), and if so how these
signals may differ. There are 3 important differences between gdTCR and preTCR
expression by immature thymocytes. First, the structure of the two receptors is different, i.e.
the γδTCR is composed of variable γ and δ chain, while the pre-TCR is composed of a
variable β chain and an invariant pTα chain. Secondly, the expression levels differ
dramatically, such that gdTCR expression is readily observed by surface staining, while the
preTCR is almost undetectable at the cell surface. Finally, there is evidence that at least
some gdTCRs can recognize intrathymic ligands, while the preTCR apparently lacks this
capacity. Two alternate models have been proposed to explain alternate commitment to the
ab or gd lineages, i.e. instructive and stochastic/selective (25, 26).
The instructive model postulates that TCR directly instructs lineage commitment by
inducing distinct signals. The stochastic/selection model, on the other hand, postulates that
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lineage decision is independent of TCR signaling. Only thymocytes whose TCR matches
their lineage choice are able to develop along the predetermined lineage pathway, wherease
thymocytes with the wrong TCR expression are selectively eliminated by programmed cell
death. However, these models failed to fully explain all relevant experimental data. Thus
thymocytes expressing a transgenic gdTCR are nevertheless able to mature to the ab
lineage and become DP thymocytes. Another model, the quantitative instructive model, was
therefore devised to accommodate these discrepancies. According to this model stronger
TCR signals, resulting from engagement of the gdTCR by intrathymic ligands promote γδ
lineage commitment, whereas relatively weaker signals promote commitment to the αβ
lineage. In support of this model, some studies suggest that γδTCR complex more
efficiently activate downstream signaling cascade than αβTCR does (27, 28). More
recently, it was demonstrated that attenuation of γδTCR signaling diverted thymocytes
from the γδ lineage to αβ lineage (29). In this paper, KN6 γδTCR transgenic thymocytes,
which are reactive with nonclassical MHC class Ib molecule T22d, were shown to undergo
γδ lineage commitment in the presence of ligand, but ab commitment in its absence.
Cells that adopt the ab lineage undergo progression to the DP stage, where rearrangement
of the TCRa gene occurs, leading to cell surface expression of the complete abTCR. The
engagement of the abTCR complex by self peptides bound to self MHC class molecules,
generates a downstream TCR signaling cascade(30). The CD4 or CD8 molecules also
interact directly with MHC class-II and class-I, respectively, and are critical for potentiating
the TCR signal (31-33). Depending on the affinity of TCR/ligand interaction and the
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“strength” of the resulting TCR signal, cancels are selected for survival and further
development (positive selection), or undergo programmed cell death (negative selection), or
if not stimulated at all, death by neglect.  Cells that undergo positive selection, develop into
either SP CD4 or SP CD8 cells. Importantly, there is a precise correlation between CD4 or
CD8 expression and TCR specificity to either MHC class II or I, respectively. Much effort
has been dedicated to determining the mechanism by which this correlation is achieved (34-
36). Similar to gd/ab lineage choice, alternate instructive and stochastic/selective models
were initially proposed to explain CD4/CD8 lineage commitment (Figure 3). In the
instructive model, engagement of TCR by MHC class I or II molecules was postulated to
induce qualitatively distinct signals, instructing CD8 or CD4 lienage choice. According to
the stochastic model lineage choice is entirely independent of TCR and MHC class II- and
I- molecules, and is followed by a negative selection step that eliminates cells with
mismatched coreceptor expression. A common premise of these two models is that positive
selection and lineage commitment are simultaneous events that are induced at the DP stage.
After considerable effort to distinguish these simple models, it became evident that neither
could fully account for experimental evidence (37). For example, under certain
circumstances, MHC class-II specific thymocytes could mature to the CD8 instead of the
CD4 lineage. Also, transgenic mice that constitutively expresses one of the coreceptors
failed to rescue substantial numbers of mismatched thymocytes, as would be predicted by
the stochastic/selective model. Consequently, new models were devised to accommodate
these observartions.
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in particular, the so-called quantitative/instructive (signal strength model) model proposed
that lineage commitment depended on quantitative rather than qualitative differences in
TCR signaling, such that strong or weak signals promoted CD4 or CD8 commitment,
respectively (30, 38-40) (Figure 4). DP thymocytes in this model are instructed by
differences in the strength of the signals that are transduced by coengagement of TCR and
coreceptor during positive selection. In this model CD4 and CD8 molecules paly a pivotal
role in controlling TCR signal strength based on the differential affinity of their
cytoplasmic tails for a key intracellular signalling factor called tyrosine kinase p56 Lck.
Lck binds and phosphorylates so-called immunoreceptor tyrosin-based activation motifs
(ITAM) within the TCR/CD3 complex, which is the essential first step in propogating the
TCR signalling cascade (41-44). CD4 has higher affinity of intracellular Lck, so that more
Lck is recruited by its cytoplasmic tail than is the case for CD8 (45-47). Coengagement of
MHC class II ligands by CD4 and class II-restricted TCR leads to increased
phosphorylation of TCR/CD3 complex and stronger signals than does coengagement of
MHC class I ligands by CD8 and class I-restricted TCRs. This results in induction of gene
expression programs leading to CD4 lineage commitment, whereas relatively weak signal
activate the CD8 lineage development program (48). This model is supported by various
experiments (49). For instance, replacement of the CD8α cytoplasmic domain of by that of
CD4 redirects development of some class I-restricted thymocytes to the CD4 lineage (44,
50, 51).
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Recently an alternate kinetic signaling model has been proposed, whereby lineage choice is
instructed by differences in signal duration rather than strength (52, 53). In this model, long
or short duration of TCR signal instructs thymocytes to undergo CD4 or CD8 commitment,
respectively. Differences in TCR signal duration may arise due a peculiarity of thymocyte
developemnt that was described more than 10 years ago, in particular that all thymocytes
developing from the DP to the SP CD8 and CD4 stages go through an intermediate stage
where CD8 expression is selectively downmodulated, the so-called CD4+8lo stage. CD8
downmodualtion selectively impairs MHC class-I restricted TCR signalling but does not
affect MHC class-II restricted TCR signalling (54). Consequently, in CD4+CD8lo
thymocytes, TCR signalling by MHC class-I restricted thymocytes is specifically
interrupted, while signalling by MHC class-II restricted thymcoytes is unaffected (55-57).
In support of this model, it’s been shown that many CD4+CD8lo cells remain uncommitted
to either lineage, consistent with the view that commitment occurs at this stage, rather than
the earlier DP stage. According to the kinetic signaling model, CD4/CD8 lineage choice is
therefore determined by developmentaly regulated downmodulation of CD8. After DP
thymocytes terminate CD8 gene transcription, lineage choice is determined by persistence
or absence of TCR signaling. If the TCR mediated signal persists, thymocytes differentiate
into CD4 lineage cells, while if TCR-mediated signal ceases, cells differentiate into CD8+
T cells (37, 58).
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Figure 3. TCR Signaling Model for
Lineage Commitment (A) Instructive and
stochastic-selective models of lineage
commitment. According to the one-step
instructive model, coengagement of MHC
class I–restricted TCR and CD8 or MHC
class II–restricted TCR and CD4 induces
alternative signals that promote specific
CD8 or CD4 lineage programs of gene
expression and lead directly to silencing of
the inappropriate coreceptor. In contrast, the
stochastic-selective model involves two
steps: a random lineage choice, and
selection of thymocytes whose coreceptor
expression matches their TCR specificity,
which requires signal mediated by
coengagement of TCR and coreceptor.
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Figure 4. Quantitative-Instructive Model vs. Signal Duration Model (A) Quantitative-
instructive model of lineage commitment. Different signal intensities result from the
developmentally programmed reduction in CD8 expression at the CD4+8lo stage, which
selectively impairs signaling by class I-restricted TCRs. Final commitment does not occur
until the CD4+8lo stage. (B) Combined quantitative/kinetic model of lineage commitment.
This model combines key aspects of the quantitative instructive and kinetic signaling
models. Class I–restricted cells receive a relatively weak TCR signal at the DP stage owing
to the weaker interaction of Lck with CD8_ than with CD4, as postulated by the
quantitative instructive model. Low-affinity class I–restricted cells, which would receive
the weakest signal of all thymocytes, would be directed immediately to the CD8 stage,
without traversing the CD4+ 8lo intermediate stage. High-affinity class I–restricted cells,
like all class II–restricted cells, would receive a stronger signal that drives development to
the CD4+ 8lo stage. Downmodulation of CD8 at the CD4+ 8lo stage would specifically
impair signaling by high-affinity class I–restricted cells and thus prevent their development
to the CD4 lineage.
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5. Transcriptional Regulations of CD4/CD8 Lineage Fate
As outlined above, considerable effort has been devoted to elucidating the effect of TCR
and coreceptor-mediated signaling on lineage choice. Another approach to revealing the
underlying molecular pathways that control lineage choice has been the so-called  ”bottoms
up” strategy, which proposes to define transcriptional control mechanisms of lineage
specific genes (59-61). This approach has led to important insights into the transcriptional
control of the CD4 (62, 63) and CD8 genes (64-68), in particular. It was demonstrated that
Cd4 gene expression is controlled in a stage- and lineage-specific fashion by a
transcriptional silencer (CD4 Silencer) (62), that represses CD4 transcription in both DN
and CD8+ thymocytes. Cd8 gene expression, on the other hand, is regulated in a more
complicated manner by several enhancers with partly overlapping stage- and lineage-
specific activities. Conserved Runx binding sites, were identified within the CD4 silencer
which were essential for repression of  CD4 gene in the CD8 lineage. Runx3 is selectively
induced in SP CD8 thymocytes, consistent with a key role in silencer-mediated
transcriptional repression of CD4 in these cells (69). Additionally, it was reported that
Runx has a dual function for positive regulation of Cd8 gene transcription. These findings
led to the conclusion that induction of Runx3 expression is a key event for inducing
cytotoxic CD8 T cell development (70). Nevertheless, transgenic expression of Runx3 does
not redirect MHC class-II restricted TCR cells to CD8+ lineage (71, 72), indicating that it is
necessary but not sufficient factor alone for CD8+ lineage development (73, 74).
Another transcription factor that plays an important role in alternate lineage development is
the zinc finger transcription factor GATA-3 (75-77). GATA-3 is expressed in the earliest
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progenitor T cell and required for thymocytes to differentiate beyond DN stage. It is
upregulated by TCR signaling in DP thymocytes and is more highly expressed in CD4+
cells. Conditional deletion of GATA-3 gene in DP thymocytes markedly decreases CD4+ T
cells numbers without affecting CD8+ T cells, which indicates a crucial role of GATA-3 in
CD4+ T cell survival and differentiation (77). Additionally, constitutive expression of
GATA-3 selectively inhibits CD8+ T cell development, but fails to redirect MHC class-I
restricted cells to CD4+ lineage (76). These results indicate that GATA-3 is necessary for
CD4 development, but does not control lineage commitment itself.
6. ThPOK; The Master Regulator of CD4/CD8 Lineage Commitment
The Kappes lab identified a spontaneous mutant mouse line that exhibited selective absence
of mature CD4 T cells, and increased representation of CD8 cells, refered to as “helper-
deficient” or HD mice (78). The responsible mutation was localized to the gene encoding
the Zn finger transcription factor Th-POK (T-helper inducing POZ-Kruppel like factor)
transcription factor. In HD mice, MHC class-II restricted cells fail to differentiate into
CD4+ T cells and instead differentiate into CD8+ lineage. The point mutation of ThPOK in
HD mice alters a residue in the zinc finger domain directly interacting with DNA, so that
the HD phenotype seems to reflect a loss-of-function by this factor. HD mice were different
from inactive Lck transgenic mice, which impaired TCR signaling, suggesting that the
mechanism of redirection of HD mice is not an indirect outcome of impaired TCR signaling
(79, 80). Biochemical assays confirmed that HD mice exhibit normal TCR signaling.
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ThPOK, also known as Zfp67, cKrox or Zbtb7b, belongs to the POK family of transcription
factors, and encodes 2 functional domains, i.e. a Kruppel-like zinc finger domain that is
responsible for DNA binding and a BTB-POZ domain, which is implicated in
homodimerization and recruitment of other factors (81). Constitutive expression of ThPOK
causes redirection of MHC class-I restricted cells to the CD4+ lineage in HD and wild type
backgrounds. mRNA levels of ThPOK are much more highly expressed in MHC class II-
than class- restricted thymocytes, consistent with an instructive role in determining lineage
choice.  In HD and ThPOK transgenic mice, redirected thymoctyes express appropriate
lineage-specific markers, i.e. redirected class II-restricted cells in HD mice express other
CD8 specific genes like perforin, indicating that ThPOK controls the overall lineage
commitment process, not just coreceptor expressions (82). ThPOK expression is
maintained in the peripheral CD4+ T cells, implying that it has other significant functions
after a full maturation. Indeed, terminating ThPOK expression in mature CD4 cells leads to
aberrant derepression of CD8. The fact that MHC class-II restricted cells are redirected to
the CD8 lineage in HD mice, indicates that CD8 commitment does not require a specific
mediator analogous to ThPOK, but is apparently a default pathway.
The observation that constitutive ThPOK expression induces MHC class-I thymocytes to
adopt the CD4+ lineage is in principle supportive of a quantitative/instructive rather than
stochastic/selective model of lineage choice. It is also fully compatible with the kinetic
signaling model. In particular, the percentage of intermediate CD4+CD8lo thymocytes is
considerably increased in HD mice compared to wild-type mice, consistent with the idea
that CD4+8lo cells are the stage at which lineage choice occurs. Imporatntly, class II-
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restricted CD4+8lo cells from HD mice are not arrested in development but undergo further
development to the CD8 lineage.
ThPOK was originally cloned as binding factor and negative regulator of collagen gene
promoters (81, 83). This is consistent with the known role of the POZ domain and
established functions of other POK family members, like Bcl-6 and PLZF (84). The POZ
domain mediates chromatin-remodeling by interacting with histone deacetylases or other
factors and is involved with transcriptional repression. This suggests the hypothesis that
ThPOK may act as a transcriptional repressor that blocks the CD8 lineage-specific gene
expression program. The next challenges will be to identify the intracellular factors that
control ThPOK induction and define the downstream target genes that ThPOK binds to and
regulates (85).
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II. Specific Aims
(1) How is ThPOK regulated at the level of transcription?
1. Is ThPOK transcription regulated by TCR signaling?
There is considerable evidence to suggest that CD4/CD8 lineage choice is regulated by
differences in TCR signaling. Further, previous work from the Kappes lab has shown that
CD4/CD8 lineage choice is controlled by differential availability of ThPOK in developing
thymocytes. Together these observations suggest the hypothesis that differences in TCR
signaling control the level of ThPOK transcription, which in turn determines lineage
choice. We propose to formally test the effect of strong TCR signals on ThPOK expression
using an in vivo antibody-mediated TCR stimulation assay. This involves exposing MHC
class I-restricted thymocytes, which would normally not express ThPOK to anti-TCRb
antibodies, and measuring mRNA levels of ThPOK by real-time RT PCR.
2. Mapping potential cis-acting regulatory elements at the ThPOK locus.
Since differential transcription of ThPOK controls lineage choice, it is important to define
the cis elements that control ThPOK transcription, in order to unravel the important
upstream pathways that determine lineage choice. Because DNase I Hypersensitive Sites
(DHS) often correspond to important cis elements, includng promoters and enhancers, we
propose to carry out detailed DHS analysis of the entire ThPOK locus. In prev ious
experiments it has been determined that a 30kb genomic fragment containing the ThPOK
gene is sufficient to mediate normal lineage choice, indicating that all essential cis elements
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are contained within this fragment. Mapping of the key cis-elements within this fragment
represents a necessary first step to subsequent identification of trans-acting factors that bind
to these regulatory elements.
3. Do DHS sites correspond to important functional elements? To examine the in
vivo function of DHS sites, a series of ThPOK-GFP reporter transgenic mice were
generated in which different DHS sites identified at the ThPOK locus were selectively
deleted. This loss-of-function analysis will demonstrate which elements are necessary for
normal lineage-specific regulation of ThPOK transcription. Indeed, most DHS sites were
found to correspond to important cis elements, including promoters and enhancers.
Premlimianry experiments indicated a critical role for one DHS site at the 5’ end of the
ThPOK locus, which was  designated the distal regulatory element (DRE).
4. What is the role of the Distal Regulatory Element (DRE)?
To precisely delineate the role of the DRE in ThPOK regulation, we generated 2 new
transgenic reporter constructs in which the 500bp DRE element was specifically deleted, or
in which it was connected to a minimal T cell-specific promoter, which by itself is not
sufficient to mediate expression in vivo. These experiments demonstrated that the DRE is
both necessary and sufficient for lineage-specific regulation of ThPOK transcription. The
DRE encodes both enhancer and silencer activities. The DRE-encoded silencer is capable
of fully blocking activity of 2 enhancer elements at the ThPOK locus, i.e. the PRE and GTE
32
enhancers, in the CD8 lineage. Deletion of the DRE leads to promiscuous activity of the
GTE enhancer in all thymocytes.
5. Functional dissection of the DRE regulatory element.
In this aim we utilized in vitro transfection and in vivo transgenic reporter assays to
characterize the functional roles and possible synergistic interactions between regulatory
elements. A number of potentially significant trans-acting factor binding sites were
identified within the DRE element, including Runx, Ebox, NfκB and Gata consensus sites.
The potential significance of these sites has been be tested by mutational amalysis in GFP
reporter transgenic mice, suggesting an important potential role for Ebox and NfkB sites.
Ultimately, to demonstrate a physiological role for specific cis-acting elements, we will
employ a knockout approach to delete individual regulatory elements in the germline.
6. Identification of trans-acting factors that bind to the DRE.
We performed electrophoretic mobility shift assays (EMSA) to identify putative trans-
acting factors that can interact with the core DRE element. For this purpose we utilized
thymocytes from different transgenic mouse strains, which are enrichedc for different
thymocyte stages, i.e. DP, SP CD4 and SP CD8. Further in vivo assessment of factor
binding will be carried out with the chromatin immunoprecipitation (ChIP) assay.
(2) Role of ThPOK in γδ Thymocytes
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1. Is ThPOK expressed in γδ thymocytes?
As mentioned previously, differences in TCR signal strength are postulated to control
alternate CD4/CD8 linage choice. A similar model has been proposed to explain choice
between adoption of the gd or ab lineages at the DN stage of thymic developemnt. Because
the two mechanisms controlling the twop processes seem similar, we asked whether
ThPOK might also paly a role in development of gd thymocytes.  We first utilized
GFPThPOK reporter mice to assess whether ThPOK was in fact expressed in gd thymocytes.
We found that ThPOK is selectively expressed in a significant fraction of γδ lymphocytes,
particularly those that exhibit the mature CD44+ CD24- phenotype. In HD-/- mice, which
lack functional ThPOK,  the absolute number of mature gd thymocytes is drmatically
reduced, indicating an essntial role for ThPOK in their gd commitment and/or maturation.
On the other hand, constitutive expression of ThPOK in GFPThPOK mice results in greatly
tincreased numbers of mature γδ cells.
2. Is ThPOK induced by γδ TCR signaling?
Recently, we and others have proposed that γδ/αβ lineage choice is controlled by strength
of TCR signaling and that relatively strong TCR signals promote the γδ lineage.
Nevertheless, the role of TCR signaling in γδ T cell development remains highly
controversial. Given the important role of ThPOK in gd developemnt, we have tested
whether there is a relationship between TCR signaling and ThPOK induction in γδ
thymocytes. For this purpose we used both in vitro cell culture assays and in vivo mouse
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models, in which the strength of TCR signaling can be modulated. For the in vitro assay, γδ
thymocytes were cultured on plates coated with different concentrations of anti-TCR
antibodies. For the in vivo assay, we utilized KN6 mice which express a gdTCR transgene
that recognizes T10b and T10d ligands expressed by thymic epithelial cells. Since affinity
of the KN6 TCR is much higher for T10b than T10d, crossing the KN6 TCR onto genetic
backgrounds that express only one or the other ligand allows us to test the effect of TCR
signal strength on ThPOK induction in vivo. Indeed, in both in vitro and in vivo models we
found a direct correlation between TCR signal strength and ThPOK induction.
3. What is the role of ThPOK in development and maturation of γδ thymocytes?
In previous studies, we showed that ThPOK is a key regulator of CD4 commitment. We
therefore asked whether ThPOK similarly controls lineage choice by developing gd
thymocytes, or plays a different role in this developmental context. gd thymocytes diverge
into 2 functionally distinct subsets in the thymus that express NK1.1 or CCR6 surface
markers, and have the capacity to secrete either IFNg or IL17 in response to antigen
stimulation, respectively. We therefore asked whether development to these alternate gd
“lineages” was perturbed in mice that lack functional ThPOK or express ThPOK
constitutively.  In previous experiments we found that the abolute number of mature γδ
thymocytes was drastically diminished in HD-/- mice, and increased in ThPOKconst mice.
Further analysis revealed that this mostly involved perturbation of the NK1.1+ IFNg-
secreting subset, while the CCR6+ IL17-secreting subset of gd cells was relatively
unaffected. We have carried out additional experiments to determine whether this reflects
35
ThPOK-mediated control of NK1.1/CCR6 lineage choice itself, or a specific role of
ThPOK in promoting development of cells already committed to the NK1.1+ lineage.
Preliminary data supports the latter possibility.
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III. Results
(1) How is ThPOK regulated at the level of transcription?
The process of CD4/CD8 lineage commitment has been intensively studied as an important
model of binary lineage choice. Although some transcription factors involved in this
process have been identified, the key regulators have remained unknown. The notion that
TCR signal strength or duration may control lineage choice, suggests that important
downstream mediators of CD4 commitment are specifically induced and/or activated  by
strong TCR signals. The identification of ThPOK as a key regulator of lineage commitment
opens a new window into the study of the transcriptional regualtion of CD4/CD8
commitment. This gene was identified as a result of studies of mutant HD mouse, which
exhibit a selective defect in CD4 commitment. A point mutation at the Th-POK locus was
identified as the cause of the HD phenotype, which resulted in redirection of MHC class II
–restricted thymocytes to the CD8 lineage. In the first part of the current study, we have
examined the relationship between TCR signaling and ThPOK expression and have found a
direct causal relationship between the two. Furthermore, we identified several cis-acting
elements at the ThPOK locus, including promoters, enhancers and silencers, that
collectively are necessary and sufficient for normal transcriptional regulation of ThPOK. In
particular we have identified the distal regulatory element (DRE) as the key element that
controls lineage-specifci regulation of ThPOK. Mutational analysis of the DRE element
provides important clues towards the eventual identification of trans-acting factors that
regulate DRE activity and hence stage- and lineage-specific expression of ThPOK.
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1. ThPOK in developing thymocytes is regulated by TCR signaling
During thymic development, ThPOK transcription is first detected at the CD4+CD8lo stage,
an obligatory intermediate stage during development of both SP CD4 and CD8 lineages.
The development of DP thymocytes to the CD4+8lo stage depends on TCR signaling, as
evidenced by expression of activation markers such as CD69. It has been debated whether
lineage commitment is induced by TCR signaling at the DP or at the CD4+8lo stage. We
therefore tested directly whether ThPOK could be induced by strong TCR signals in these
subsets. For this purpose we utilized both in vitro and in vivo systems. In vitro stimulation
of DP thymocytes with plate-bound anti-TCRb antibody failed to induce ThPOK by 24hrs.
Because of the limited life-span of immature thymocytes in vitro it was not possible to
extend these experiments to longer time periods, so that it cannot be excluded that ThPOK
induction is a relatively late outcome of TCR stimulation, i.e. occurring >24hrs after
stimulation. To explore this further we administered anti-TCRb antibody directly into live
mice, so that viability of thymocytes is not a limiting factor. These experiments were
carried out in mice carrying a germline deletion in the MHC class II locus (I-Ab-/- mice),
which lack expression of MHC class-II molecules, and therefore only support positive
selection of MHC class-I restricted cells to the CD8 lineage. The circulating TCRb
antibody reaches the thymus, where it binds to TCR and induces strong TCR stimulation.
Importantly, class I-restricted thymocytes normally express only low levels of ThPOK.
Following antibody stimulation a large population of SP CD4 thymocytes develops within
2 days. Most significantly, we detected simultaneous strong induction of ThPOK in
38
CD4+8lo thymocytes by 2 days. However, ThPOK induction was never detected in DP
thymocytes, even though they clearly received a TCR signal, as evidenced by expression of
the activation marker (Figure 5, A, C). We conclude that strong TCR signals are necessary
to induce ThPOK in vivo and that ThPOK induction occurs at the CD4+8lo rather than DP
stage. Conversely, we tested whether continued expression of ThPOK by CD4+CD8lo
thymocytes requires persistent TCR signallng, i.e. whether cessation of TCR signaling
interrupts ThPOK expression. For this purpose, we isolated CD4+CD8lo thymocytes from
MHC class-I deficient (β2M-/-) on the HD-/- background. In such mice, thymocytes
undergo positive selection by MHC class-II ligands, but are unable to undergo CD4 lineage
commitment due to lack of functional ThPOK, and thus eventually develop into CD8 cells
both in vivo and in vitro (data not shown). Nevertheless, strong class II-restricted TCR
signals result in high level induction of mutant ThPOK mRNA in freshly isolated CD4+8lo
cells from these mice (Figure 5 D). When cultured in vitro overnight these cells lose contact
with thymic antigen-presenting cells resulting in termination of class II-mediated TCR
signaling. Importantly, these “unsignaled” cells also lose ThPOK expression. In contrast, if
tehse cells are exposed to anti-TCR antibody to provide a strong TCR stimulus, ThPOK
expression is maintained. Hence, persistent TCR signaling is required for maintainenance
of ThPOK expression by CD4+8lo cells. Overall, these observations demonstrate a srong
correlation between strong TCR signallng and ThPOK expression in CD4+CD8lo cells
preceding lineage choice.
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Figure 5. Strong TCR stimulus induces ThPOK mRNA expression in CD4+8lo
thymocytes. (A) MHC class-II-deficient mice were injected with TCRβ antibody, and
analyzed at indicated time point by Real-Time RT-PCR. The graphs represent mean ±
standard deviation (SD) (n=2). (B) Sorted CD4+8lo thymocytes from B2m-/- HD-/- mice
were incubated overnight in the presence or absence of antibody, and ThPOK mRNA level
was  analyzed level by Real-Time RT-PCR on indicated populations. The graphs represent
mean ± SD (n=2). (C) A comparison of CD69 expression in gated DP and CD4+8lo subsets
before or 4 days after antibody treatment. (D) Sorted CD4+8lo thymocytes from B2m
Zbtb7bHD/HD mice were incubated overnight in the presence or absence of indicated
antibodies, and real-time RT-PCR analysis of ThPOK mRNA was performed on indicated
populations. The graphs represent mean ± SD (n = 2). Numbers in the FACS plot represent
percentages of the associated gate. Each experiment was repeated at least three times with
similar results.
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2. Mapping important cis-acting regulatory elements at the ThPOK locus.
The interaction between specific trans-acting factors and cis-acting elements is critical for
proper control of transcription. Important cis-acting regulatory elements include promoters,
enhancers, and silencers. Identifying cis-acting elements is an essential first step in
elucidating the transcriptional control mechanisms that govern the expression of particular
genes. An important method for identifying potential transcriptional regulatory elements is
the DNase I hypersensitivity (DHS) assay. The structural configuration of chromatin plays
a significant role in transcription, because the open structure is necessary to allow access by
trans-acting factors. Sensitivity to DNase I identifies regions of chromatin that are in an
open configuration, because the exposed regions can easily be modified by nuclease
enzymes, like DNaseI. Therefore, DHS sites often identify important cis-acting elements
that are bound by trans-acting factors. To better understand developmental and stage-
specific regulation of Th-POK transcription, we carried out DHS analysis of a 30kb region
encompassing the ThPOK gene.
To first determine the minimal genomic region necessary for normal regulation of ThPOK,
we generated a series of transgenic lines in which the ThPOK gene was flanked by different
lengths of adjoining genomic DNA, ranging from 17kb to 200kb. Eack transgene was
backcrossed to the HD-/- background to determine whether they could support CD4
developemnt in the absence of endogenous ThPOK. Importantly, a genomic fragment as
small as 26kb could rescue normal lineage commitment (construct SPE7.6), as evidenced
by restoration of normal proportions of CD4 and CD8 T cells  (Figure 6 A). Not only was
CD4 development restored, but only class II-restricted cells developed to the CD4 lineage,
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as in normal mice, while class I-restricted cells developed appropriately to the CD8 lienage.
Hence, all elements necessary for correct lineage- and stage-specific transcription of
ThPOK are contained within the 26kb fragment. Significantly, if a 6kb region at the 5’ end
of the 25kb fragment was deleted (construct REC3.33) CD8 development was severely
impaired, suggesting that ThPOK expression was not appropriately suppressed in MHC
class-I restricted thymocytes (Figure 6 B and C). This analysis implied that the 5’ region of
the 26kb construct contained a critical cis element required for lineage-specific regulation
of ThPOK transcription.
To identify putative regulatory elements within the minimal 26kb region necessary for
correct ThPOK regulation, we performed DHS analysis. Analysis of evolutionary
conservation of the ThPOK locus between different mammalian species identified several
non-protein coding regions that were highly conserved, and thus were most likely to
contain important conserved cis elements. Several hybridization probes were carefully
designed to allow comprehensive assessment of DHS sites across the entire 26kb minimal
ThPOK region, and particularly of the evolutionarily conserved regions (Figure 7 A). A key
consideration in selecting probes for DHS analysis is that they should be located near the
ends of restriction fragments, thereby allowing unambiguous mapping of DHS sites relative
to the position of the probe (if the probe is near the center of the restriction fragment, it is
often difficult to determine from the size of the DHS fragment whether the cut site lies to
the right or left of the probe). To assess whether DHS sites change according to thymocyte
developmental stage or lineage, we isolated genomic DNA from thymocytes of 3 different
kinds of mice: 1) CD3δ-/- mice, in which thymic development is blocked at the DP stage,
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i.e. before commitment to either CD4 or CD8 lineage and before ThPOK is normally
expressed. 2) MHC class-II restricted AND TCR transgenic mice, in which 30-50% of
thymocytes belong to the class II-restricted CD4+CD8lo and SP CD4 subsets and exhibit
high levels of ThPOK expression, and 3) MHC class-I restricted OT-1 TCR transgenic
mice, in which 30-50% of thymocytes belong to the class I-restricted CD4+CD8lo and SP
CD8 subsets and low level ThPOK expression is detected only in the CD4+CD8lo subset.
These experiments identified six distinct DHS sites or clusters of sites, labeled A-F, at the
ThPOK locus, of which several were shared between different kinds of mice (Figure 7 A).
We used different concentrations of DNase I to reveal the presence of multiple DHS sites
within the same restriction fragment. Lower concentrations result in partial digests and are
useful for revealing DHS sites farthest from the probe, while highest concentrations result
in complete digestion and thus reveal only the site closest to the probe. Importantly, 2 of the
DHS sites, B and D, coincided with alternate distal and regulatory promoters, confirming
that the DHS assay was function effectively in our hands, and was identifying regions of
importance for transcription. The other sites were scattered throughout intronic and
flanking DNA, and could represent elements that act at a greater distance from
transcriptional start sites, such as enhancers and silencers. Most notably, DHS site A was
found to coincide with the conserved region at the 5’ end of the ThPOK locus, that we
previously showed was essential for correct suppression of ThPOK expression in CD8
cells, and which is lacking in the functionally defective REC3.33 construct (Figure 7 B). In
view of its likely functional significance, we refer to the 5’ region that overlaps with DHS
site A as the distal regulatory element (DRE). Sites A, C and E were not stage-specific,
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meaning that they were detected in all three strains of mice examined, including CD3δ-/-
mice which possess only DP thymocytes that do not express ThPOK. This indicates that
structural conformation of chromatin was already open these sites in DP thymocytes prior
to ThPOK transcription. The fact that transcription factors were apparently already loaded
at these sites prior to transcription could indicate that that these siotes are poised for activity
and are awaiting recruitment of additional important trans-acting factors. It’s possible that
negative regulatory factors are bound to some of these sites and that they must be displaced
by positive regualtroy factors in order to initiate transcription. Sites A, C and E did not
coincide with putative promoters and instead may represent enhancers or other types of
regulatory elements. On the other hand, sites B, D and F were preferentially detected in
MHC class-II restricted thymocytes, indicating that they are only associated with active
transcription. Sites B and D are close to distal and proximal promoters, whereas site F lies
upstream of the first coding exon.
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Figure 6. Expression pattern of the minimal ThPOK genomic fragments and a
construct lacking a conserved Distal Element (A) Schematic representation of BAC
transgenic constructs, showing location of Zbtb7b gene. The number of founders that
showed transgene expression as wll as total founders is indicated. (B) Genomic ThPOK
construct showing CD8 commitment. CD4 vs. CD8 expression pattern of PBLs from
different founder mice expressing constructs SPE7.6 or REC3.33. Note selective
diminution of SP CD8 subset in all REC3.33 founders. (C) CD4 vs. CD8 expression pattern
of PBLs from SPE7.6 or REC3.33 transgenics crossed to Zbtb7b-/- bachground, i.e., in the
absence of functional endogenous ThPOK.
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Figure 7. Multiple DHS Sites in ThPOK
Locus in primary thymocytes denote
potential regulatory elements (A)
Restriction map of ThPOK locus, showing
location of probes used for DHS analysis
and position of DHS sites or clusters
identified in thymocytes (R=EcoRI,
P=PstI,  K=KpnI, B=BamHI,
E=EcoRV) (B) Comparison of three
BAC subclones used for generation
of transgenic lines, showing
sequence conservation between
mouse and human or possum (%
homology is indicated by color;
green = 78-84, yellow=85-89,
orange=90-95, red=>95%). (C)
Representative DHS analysis using
indicated probes and restriction
enzymes. Analysis was carried out
with total thymocytes from AND
and OT-1 transgenic mice, or CD3δ-/- mice. Red arrows mark DHS sites, B, D and F are
preferentially detected in class II-restricted thymocytes.
(A)
(B)
(C)
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3. What is the functional significance of the Distal Regulatory Element (DRE)?
To assess the functional significance of the DHS sites identified above, we generated a
series of reporter transgenic mice, in which GFP is expressed under the control of different
segments of the ThPOK locus including different combinations of DHS sites (Figure 8 A).
Based on RT-PCR analysis of endogenous ThPOK expression pattern, GFP expression
should be restricted to class II-restricted CD4+8lo and SP CD4 stages, if transcription is
correctly regulated. Indeed, a construct containing all DHS sites, A-F, showed appropriate
lineage- and stage-specific regulation of GFP transcription, such that expression was
essentially limited to CD4+8lo and SP CD4 cells but undetectable in DP and SP CD8 cells
(Figure 8 B). This indicated that these DHS sites were likely to include all important cis-
acting elements. To assess the role of the DRE element (marked by DHS site A) in
particular, we generated GFP reporter constructs in which this element was specifically
deleted, i.e. construct F2F3ΔDRE Importantly, deletion of the DRE resulted in loss of
lineage-specific reporter transcription, i.e. promiscuous GFP expression in both CD4 and
CD8 lineages, indicating that this element confers CD8-lineage specific silencer activity
(Figure 9 A and B). Further deletion analysis indicated that promiscuous expression could
still be maintained by a minimal 6kb construct that included only DHS sites C-F and the
proximal promoter, suggesting that one of these sites marks a strong enhancer with activity
in both CD4 and CD8 lineages (construct F3e). Furthermore, when the DRE was inserted in
front of the F3e construct (F2cF3e), CD4 specificity and MHC class-I restricted
suppression was restored, indicating that DRE-mediated silencing activity is independent of
its distance from the promoter or enhancer elements that it suppresses. In addition,
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reversing the orientation of the DRE also did not affect silencer function (data not shown).
Overall, the data suggest that the DRE encodes a position- and orientation-independent
silencer that is indispensable for suppression of ThPOK transcription in the SP CD8
lineage.
To test whether the DRE functioned only as a negative regulatory eleemnt or might also
encode positive regulatory function, like an enhancer, we generated a reporter transgene in
which we placed the DRE upstream of the minimal hCD2 promoter, which by itself is
insufficient to mediate transgene expression in T cells (F2c-pCD2). Interestingly, the F2c-
pCD2 construct mediated strong GFP expression in SP CD4 thymocytes and peripheral T
cells, indicating that it could also function as an enhancer. To separately test reporter
expression of the F2c-pCD2 construct in MHC class-II and class-I restricted thymocytes,
F2c-pCD2 transgenic mice were crossed to mice expressing the AND and OT-1 TCR
transgenes, respectively (Figure 9 C bottom). This demonstrated that GFP expression was
higher in MHC class-II restricted than MHC class-I restricted cells already at the
CD4+CD8lo stage, i.e. before thymocytes become committed to either lineage. The fact that
the entire CD4+CD8lo population in class II-restricted AND mice expressed high levels of
the reporter indicates that ThPOK induction precedes CD4 lineage commitment. These
observations demonstrate that the DRE is necessary and sufficient for differential ThPOK
expression in committed CD4 vs. CD8 cells as well as in uncommitted class II- vs. I-
restricted CD4+CD8lo cells.
To further assess the functional siginifance of the DRE-encoded enhancer function in the
context of an endogenous ThPOK promoter, we generated additional reporter constructs
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which contain the DRE together with the distal promoter, but lack DHS sites C, D and E
(F5, F5.1, F2 and F5.3) (Figure 9 D). Importantly, all constructs including the DRE element
displayed CD4 lineage specific expression, indicating that the DRE is sufficient to mediate
CD4 specific expression in the context of the endogenous distal promoter.  Deletion of the
DRE from these constructs resulted in loss of reporter expression, indicating that the DRE
functions as an enhancer in this context. Interestingly, constructs containing only the DRE
and distal promoters show much higher expression in SP CD4 thymocytes than peripheral
CD4 T cells, suggesting that these elements may be primarily responsible for supporting
ThPOK transcription in thymocytes.  Taken together these results indicate a dual function
of the DRE element as an enhancer and a lineage-specific silencer and identify an essential
role in lineage-specific control of ThPOK expression.
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Figure 8. A 12 kb Genomic Fragment Recapitulates Normal Developmental
Regulation of ThPOK Expression (A) Top panel shows exon and intron organization of
the ThPOK locus, sequence conservation between mouse and human (% homology is
indicated by color; green = 78-84, yellow=85-89, orange=90-95, red=>95%), position of
DHS sites, and design of GFP reporter construct F2F3. (B) Histrograms of GFP reporter
expression for gated thymocytes and PBL subsets, as indicated. Right panel shows real-
time RT PCR analysis of GFP transcripts initiating at alternate distal or proximal ThPOK
promoters in sorted F2F3 thymocyte subsets.
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Figure 9.  Identification of Distal Regulatory Elements (DRE) encoding dual silencer
and enhancer function. (A) The design of GFP reporter constructs is shown. Green, gray
and red box indicate that position of DRE, minimal human CD2 promoter and GFP
reporter, respectively. The ratio next to construct name shows that GFP expression out of
total founder identified by PCR. Red and black arrows indicate DHS sites including
potential regulatory elements by DHS analysis. (B) Histograms illustrating DRE silencer
function show GFP expression for gated thymocytes and PBLsubsets of indicated reporter
lines. (C) Histograms illustrating DRE enhancer function show analysis of GFP expression
in F2c-pCD2 on a non-TCR transgenic background, crossed to class II- (AND) and class I-
(OT-1) TCR transgenic. (D) DRE mediates specific expression in class II-restricted
CD4+8lo thymocytes in combination with the distal ThPOK promoter. Histograms of GFP
expression for gated thymocytes and PBL subsets from indicated reporter lines. Data for
construct F5.3, which is not expressed at any stage.
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4. Functional dissection of the DRE element.
Because the DRE plays such a key role in controlling lineage choice, it is important to
identify the mechanism by which its activity is controlled. We hypothesized that it acts as a
switch that is regulated by MHC class-II restricted TCR signaling. Hence, we anticipate
that certain factors induced or activated by strong TCR signals are recruited to the DRE
where they antagonize its silencer function. For elucidation of this molecular pathway, an
important clue may be provided by conserved motifs within the DRE that correspond to
known consensus binding sites for particular trans-acting factors. Functional analysis has
shown that a central highly conserved 300 bp region of the DRE is sufficient for its lineage
specific regulation (data not shown). Within this region, consensus sites representing
potential transcription factor binding sites were identified using a computerized motif
search. Identified consensus motifs included potential sites for NFκB, E-box, Gata, and
Runx factors. By utilizing deletional mutagenesis in the context of GFP reporter transgenes,
we have identified a central region of the DRE that is essential for silencer function (Figure
10 A). Specifically, deletion of a cental 80bp region including NfkB and E-box motifs
abolishes lineage-specificity, suggesting that these sites may be functionally important
(Figure 10 B). In contrast, mutants that delete the Gata or Runx consensus motifs show
normal suppression of GFP expression in CD8 cells, indicating that these motifs are
dispensable for lineage-specific silencing. Although these sites are not required for
regulated GFP reporter activity, it cannot yet be concluded that they are not important for
regulation in the context of the endogenous ThPOK locus. Reporter transgenes differ
significantly from the endogenous ThPOK locus in terms of their genomic surroundings
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and copy number (transgenes tend to undergo integration as multi-copy tandem repeats.
Nevertheless these results point towards an indispensable function for the 80 bp core region
in mediating silencer activity in CD8 lineage cells (indicated in gray Figure 10 A).
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Figure 10.  Mutational Dissection of DRE Element Defines 80 bp Core Element. (A)
Schematic of DRE mutants indicating deletion boundaries, mutations, and positions of
conserved TF consensus sites. The gray box indicates the 80 bp core
region that is essential for silencer function. (B) Histograms of GFP expression for gated
SP CD4 and CD8 peripheral T cells from indicated reporter lines. Numbers in the
histograms indicate%GFP+ cells.
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5. Defining factor-binding sites within the DRE.
To begin identification of factors that bind to the DRE, we performed DNase footprinting
assays, which reveal regions of DNA that are protected by bound factors. These
experiments confirmed that putative consensus sites were partly protected from nuclease
digestion by wt thymocyte nuclear extracts (data not shown). We next carried out
electromobility shift assay (EMSA) and supershift analyses in order to determine the
protein complexes that bind to the core DRE region. This assay assesses the capacity of
labeled oligo probes to pull down protein complexes from nuclear extracts of relevant cell
types. Supershift experiments additionally employs antibodies against specific factors to
determine whether they are part of the isolated protein complex. Binding of protein factors
is assessed by montoring size of protein/DNA complexes by gel electorphoresis under non-
denaturing conditions. For these experiments, we utilized nuclear protein extracts from
thymocytes belonging to the same 3 mouse strains discussed above, i.e. 1) CD3δ-/-
thymocytes, which comprise mostly DP cells that lack ThPOK expression, 2) AND
thymocytes, which exhibit high expression of ThPOK, 2) OT-1 thymcoytes, which exhibit
low expression of ThPOK. We designed 6 EMSA probes (each 20-30 bp in length and each
including at least one consensus motif), i.e. in order from 5’ end to 3’ end of the DRE, R1,
R4, R2, B1, B2 and G1 probes (Figure 11 A). Because this region was GC-rich, many
probes showed strong binding to the ubiquitous Sp1 factor (consensus motif:
GGGGCGGGC), which rendered the experiments hard to interpret. We therefore used
competition with unlabelled Sp1 consensus motif to compete away Sp1 binding and thus
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reveal binding by other factors. Indeed, inclusion of unlabelled Sp1 competitor oligos
signficantly reduced background and enhanced our ability to visualize binding of other
factors (Figure 11 B). Specific bands corresponding to binding of unknown factors were
detected in EMSA experiments utilizing nuclear extracts from MHC class-II restricted
thymocytes (marked with green box) with the R5, R2, B1 and B2 probes, whereas extracts
from MHC class-I restricted thymocytes (marked with red box) showed binding only to the
B1 probe. This suggests that factors present in extracts from MHC class-II restricted cells
might specifically interact with  E-box and NFκB binding motif present in B1, B2 and R2
probes (Figure 11 C). Of note, these bands were comparatively weak but not entirely
lacking using extracts from class-II restricted thymocytes, suggesting that these factors are
also present in the latter cells, albeit at lower levels or with lesser binding capacity.
Although, the B1 probe, which is located within the essential 80bp core DRE region and
includes both NFκB and E-box binding sites (separated by about 30bp) pulled down
similar-sized protein complexes from both class-II and class-I restricted extracts, dividing
this probe into smaller fragments revealed specific binding by class II-restricted extracts for
one of the fragments, i.e. RB1. Overall, these experiments indicate that nuclear extracts
from class II-restricted thymocytes harbor increased amounts of protein complexes that
bind to the DRE region, compared to extracts from class I-restricted thymocytes. EMSA
supershift analysis employing antibodies against NfkB and E-box binding factors HEB and
E2A suggest that these factors are not responsible for this binding. Future experiments will
seek to identify the responsible factors usning biochemical approaches.
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Figure 11. EMSA Assay in core DRE of ThPOK locus. (A) Positions of probes in core
region of ThPOK locus (B) SP1 supershift assay utilizing anti-SP1. Nuclear proteins are
extracted from wt (wild type), δ-/- and AND mice. (C) DRE region was scanned by split B1
and B2 probes. The expression of ThPOK is high in AND, low in  OT-1 and intermediate
in δ-/-. (No cold probes were used)
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III. Results
(2) The role of ThPOK in γδ Lineage Development
Developing T cells diverge at the DN (CD4-8-) thymocyte stage into distinct γδ and ab
lineages, that adopt different developmental pathways, and express different TCR isoforms.
In particular, gd thymocytes are marked by expression of the γδTCR and mostly retain the
DN phenotype throughout their existence, while cells committed to the ab lineage progress
to the DP stage and eventually express the abTCR (or, if failing to do so, undergo “death by
neglect”). Although γδ thymocytes represent a numerically minor component of total
thymocytes, they play critical roles in innate and adaptive immunity. Recently, it was
proposed that alternate development of γδ and αβ lineages is dependent on relative TCR
signaling strength. In particular, it was proposed that strong TCR signaling induces
development to the γδ lineage, whereas relatively weak signaling directs development to
the αβ lineage. Because a similar signal strength model has been proposed to control
CD4/CD8 lineage, and because of the importnmat role that ThPOK plays in this process,
we decided to examine whether ThPOK might also play a role in development and/or
commitment of γδ thymocytes (Figure 12).
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Figure 12. ThPOK expression is correlated with strong TCR signaling for lineage
commitment. As we shown that ThPOK is a ciritical mediator of CD4/CD8 lineage
commitment, the similar context can also be applied to  γδ/αβ lineage commitment,
maturation, differentiation, maturation and/or proliferation.
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1. Is ThPOK expressed in γδ lineage thymocytes?
To elucidate the expression pattern of ThPOK in γδ cells, we initially assessed ThPOK
mRNA levels in sorted gd thymic subsets either by real-time PCR analysis, or by flow
cytometric analysis of  GFP reporter expression in mice carrying a ThPOK-GFP reporter
transgene. Previous reports have demonstrated that ThPOK is selectively induced in ab
thymocytes in cells undergoing development to the CD4 lineage (78, 82). This analysis
further showed that ThPOK transcription is initiated at the CD4+CD8lo stage, but is lacking
an the prior DP stage of development (85). ThPOK expression in the even earlier DN
subset was apparently quite low overall, but was not examined in great detail.  We therefore
decided to undertake a careful reexamination of this issue. DN thymoctyes can be
subdivided into three main categories, based on their TCR surface expression pattern,
immature TCR low cells, which express neither gd nor abTCR at high levels, and instead
mostly express the preTCR (consisting of the TCRb chain in combination pTa, an invariant
“surrogate” TCRa chain), 2) mature NKT cells, which represent a distinct lineage, that
expresses αβTCR and is derived from DP precursors by downmodulation of both CD4 and
CD8, and 3) γδTCR thymocytes, which consist of immature and mature subsets. As
mentioned, ThPOK expression had not been precisely examined in these different DN
subsets, in spite of its importanrt known role in TCR-dependent lineage determination.
Given the evidence that development to the γδ lineage requires relatively strong TCR
signals, like CD4 development, we thought it particularly interesting to explore a possible
role of ThPOK in γδTCR thymocyte development. Initially, we therefore assessed GFP
expression in different gated DN subsets using our ThPOK-GFP transgenic reporter mice,
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in which GFP expression is controlled by ThPOK regulatory elements (Figure 13 A).
Initially, ThPOK expression was examined in ThPOK-GFP mice, which utilize an
expression vector that includies all control elements and promoters previously identified at
the ThPOK locus. Significantly, GFP expression was detected in two distinct populations
within the DN compartment. iNKT cells, defined by the αβTCR+ CD44+ phenotype,
expressed uniformly high GFP levels. In addition, a subset of γδTCR+ thymocytes
expressed lower, but nevertheless clearly evident, levels of GFP . Of note, iNKT (invariant
natural killer) cells express an invariant TCRα and mostly recognize a lipid antigen in the
context of the non-classical MHC class I product, CD1d (86). ThPOK expression in the
iNKT subset is consistent with recent collaborative studies (with the Kronenberg lab) that
showed development of iNKT cells to be severely impaired in the absence of functional
ThPOK (87). Significantly, real-time RT PCR analysis confirmed that GFP+ but not GFP-
γδTCR+ thymocytes expressed endogenous ThPOK mRNA, indicating that the ThPOK-
GFP reporter accurately tracks expression of the ThPOK locus in gd thymocytes (Figure 13
B). We further examined a reporter transgenic line, DREGFP mice, in which GFP expression
is specifically controlled by the 500bp distal regulatory element (DRE), located at the 5'
end of the ThPOK locus (in conjunction with a minimal T cell-specific hCD2 promoter).
Both ThPOK-GFP and DRE-GFP transgenic mice mediate lineage specific reporter
expression in ab thymocytes, i.e. in CD4 but not CD8 cells, demonstrating that the DRE is
sufficient for this purpose (85, 88) (Figure 12 B). Like ThPOK-GFP mice, thymocytes from
ThPOKGFP mice also showed selective expression of endogenous ThPOK in GFP+ γδ but
not in GFP- γδ subsets, demonstrating that reporter expression provided an accurate
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depiction of ThPOK transcriptional activity in the γδ lineage, not a transgenic artifact (Fig.
13 C). Of note, neither reporter construct included ThPOK coding exons, the region
detected by our ThPOK RT-PCR assay, so that ThPOK transcripts were certainly derived
from the endogenous ThPOK locus, rather than the reporter transgene. DREGFP mice further
demonstrate that the DRE element is sufficient for normal regulation of ThPOK in γδTCR+
DN thymocytes. Although these studies demonstrate ThPOK expression within the gd
lineage, it is noteworthy that only 5-10% of γδTCR+ DN thymocytes express GFP in either
ThPOKGFP or DRE-GFP mice, suggesting that ThPOK expression marks a distinct subset
or developmental stage of gd thymocytes  (Figure 13 B). Finally, we showed that 15-20%
of peripheral γδ cells from spleen and lymph nodes also expressed GFP, indicating that
ThPOK transcription was sustained in some peripheral γδ T cells (data not shown).
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Figure 13.  ThPOK expr67ssion by DN thymocyte subsets. (A) Diagrams of ThPOK-
GFP and DRE-GFP reporter constructs. White bar represents ThPOK gene, with exons and
DRE indicated in black and red, respectively.  (B) FACS analysis of GFP expression by
indicated gated DN thymocyte subsets from ThPOK-GFP or DRE-GFP transgenic mice
(left-hand panels).  Note distinct population of GFP+ CD24- cells in γδTCR+ thymocytes
from reporter lines, which are absent in control mice. (C) Real-time RT PCR analysis of
GFP and endogenous ThPOK expression in sorted γδTCR+ thymocyte subsets from DRE-
GFP transgenic mice (right panel).  Note the correlation between GFP and endogenous
mRNA expression. Data is derived from 3 DRE-GFP mice, and error bars represent
standard deviation.
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2. ThPOK expression in γδ thymocytes marks mostly mature/activated cells
Because only a fraction of gd thymocytes expressed ThPOK, we carried out additional
experiments to determine whether these cells were functionally and/or phenotypically
distinct from other gd thymocytes. For this purpose we subdivided gd thymocytes into
several distinct subsets, using a series of additional cell surface markers. In particular,
surface expression of CD24, CD44 and CD25 is commonly used to subdivide gd
thymocytes into three major developmental stages, i.e. in order of maturation CD24+
CD44-CD25+ (DN3) stage, CD24+ CD44- CD25- (DN4) stage, and finally CD24- CD44+
CD25- (mature γδ) stage. In mature CD24- CD25- stage, CD44 becomes reexpressed
causing phenotypic similarity to the early CD44+ CD25- (DN1) stage, but the mature
γδTCR cells can be readly distinguished from these DN1 cells by expression of gdTCR and
the absence of CD24. By utilizing transgenic reporter mice, we found that most mature
(CD24-) gd thymocytes are GFP+, while most immature (CD24+) γδTCR thymocytes are
GFP-. Consistent with this observation, mature and immature gd thymocytes show
relatively high and low expression of endogenous ThPOK mRNA. The fact that that
ThPOK expression in γδTCR+ DN thymocytes was mainly restricted to the mature fraction
suggested that ThPOK is induced in a stage-specific manner in the gd lineage.
Nevertheless, a small but significant fraction of immature (CD24+) gd thymocytes also
express GFP (Figure 13 A). Given that immature (CD24+) gd cells are the presumed
precursors of mature (CD24-) cells, this implies that ThPOK expression was initially
induced in a subset of immature gd thymocytes, and then peaks at the mature (CD24-) γδ
stage. The increase in the proportion of GFP+ γδ cells during the transition from immature
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to mature stages suggests that ThPOK may play a physiological role in γδ maturation.
Indeed, in HD mice, the absolute number of mature γδ thymocytes is substantially reduced
(by 50-70%), demonstrating a key role for ThPOK in commitment/maturation of γδ
thymocytes and/or in proliferation/survival of mature γδ thymocytes (Figure 17 A).
Mature γδ thymocytes in adult mice can be further subdivided into 2 major subsets
based on surface marker and cytokine expression pattern. One subset, preferentially
expresses IFNγ upon stimulation, and predominantly expresses the Vγ1.1 segment and the
NK1.1 surface marker (and are therefore sometimes referred to as NKT γδ cells) (89-91). A
second γδ subset preferentially secretes IL17, preferentially utilizes Vγ2, and expresses the
CCR6 surface marker (90, 91) (Figure 14 A, Figure 21 B). In the thymus, NK1.1+ and
CCR6+ γδ subsets are found exclusively within the mature CD24- fraction, each subset
contributing 30-40% of this fraction. The upstream signals and transcriptional pathways
that promote alternate development into these two functionally distinct γδ subsets are
poorly understood. However, it has been reported that antigen-experienced γδ cells develop
preferentially into the IFN_-producing subset (92). Comparison of NK1.1+ and CCR6+ γδ
thymocytes from ThPOK-GFP reporter mice shows that the former expresses higher levels
of GFP, suggesting a more important role for ThPOK in their development (Figure 14 B).
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Figure 14.  ThPOK expression by __ thymocytes increases with maturation. (A )
FACS analysis of γδTCR+ DN  thymocytes from  DRE-GFP  mice  stained  with  anti-
γδTCR, -TCRβ, -CD24, -CD44 and -NK1.1.  GFP expression is shown for indicated
γδTCR+ subsets (left-hand panels).  Note that GFP expression is evident in a minority of
immature (CD24+) γδTCR+ thymocytes, but a majority of mature (CD24+) γδTCR+ cells.
(B) Real-time RT PCR analysis of endogenous ThPOK expression for indicated sorted
γδTCR+ thymocyte subsets from DRE-GFP transgenic mice (right panel).  (C) FACS
analysis of γδTCR+ DN thymocytes from DRE-GFP mice stained with anti-CD24, -CD44,
-CD25 and –Vγ1.1. DN3, DN4 and mature (CD24- CD44+) fractions were gated and
reanalyzed for GFP expression.  Vγ1.1 expression is plotted for gated GFP+ and GFP-
subsets from each stage (right panels).  Shaded histograms represent background
fluorescence of equivalent gated thymocyte subsets from non-transgenic control mice.
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3. ThPOK is induced by strong TCR signaling in γδ thymocytes.
There is accumulating evidence that ThPOK induction in _β T lymphocytes is regulated by
strength and/or duration of TCR signaling. In the context of γδ development, we and others
have shown that the level of ThPOK mRNA expressed by transitional CD4+8lo thymocytes
correlates closely with MHC specificity, such that class II-restricted cells express much
higher ThPOK levels than class I-restricted cells. Importantly, class II-restricted CD4+8lo
cells from HD mice still express high ThPOK levels, even though these cells are actually
undergoing commitment to the CD8 lineage (78). These results indicate that ThPOK
induction at the CD4+8lo stage correlates with TCR specificity rather than ultimate lineage
choice. We have further demonstrated that antibody-mediated TCR stimulation induces
ThPOK expression by class I-restricted CD4+8lo thymocytes in vivo (85). Taken together
these observations argue strongly for a causal link between strength or length of TCR
signaling and ThPOK induction in CD4+8lo intermediate cells. Interestingly, DP
thymocytes show essentially no ThPOK expression in normal mice or in response to
antibody-mediated TCR stimulation, either in vitro (Figure 15) or in vivo (Figure 16),
suggesting that the ThPOK locus is insensitive to TCR stimulation at this stage, or that
there is a considerable lag between the inductive signal and resulting transcription at the
ThPOK locus (82, 85).
Further compelling evidence for a causal relationship between TCR signaling and
ThPOK induction arises from our analysis of γδ cells. First, the highest levels of ThPOK in
γδ thymocytes are found among the NK1.1+ IFNγ-producing subset (Figure 14 A). NK1.1
is known to be an activation marker for γδ thymocytes that can be induced by antibody-
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mediated TCR stimulation (93), and development of IFN_-producing γδ cells has been
shown to depend on ligand exposure (92). Secondly, in the KN6 γδTCR transgenic model,
ThPOK expression levels correlate with the relative affinity of the KN6 TCR for its
intrathymic ligands (Figure 16 A). The KN6 TCR recognizes nonclassic MHC class 1b
molecules, T10b and T10d, with relatively high and relatively low, respectively (94). We
therefore examined relative ThPOK levels in thymocytes from KN6 γδTCR transgenic
mice on either strong or weak TCR signaling, i.e. H-2b or H-2d backgrounds, respectively
(Figure 16 A).  For this purpose we crossed the DRE-GFP reporter transgene onto the KN6
background. Strikingly, KN6+ thymocytes showed much higher GFP expression on the
high affinity H-2b than low affinity H-2d backgrounds (Figure 16). On the H-2d
background only a minor CD24- CD44+ NK1.1+ population, comprising <0.5% of total γδ
cells, shows substantial ThPOK expression by RT-PCR (data not shown).  In contrast, in
the presence of the strong T10b ligand, most KN6+ thymocytes exhibit GFP reporter
expression, at both immature (DN3, DN4) and mature stages (CD24-). This indicates a
direct relationship between TCR signal strength and ThPOK induction in KN6 γδ
thymocytes (Figure 16 and data not shown). Finally, we showed that in vitro antibody-
mediated TCR engagement leads to ThPOK induction in γδ thymocytes, as well as in a DN
cell line that expresses a γδTCR (Park K. et als., EMBO in press). For these in vitro
experiments, immature γδTCR+ DN3 and DN4 thymocytes that had not yet expressed GFP
were sorted from DRE-GFP mice and cultured on pre-coated Petri dish with anti-γδTCR
antibody for five days. Significantly, stimulated control cultures showed substantial GFP
upregulation, confirming a relationship between ThPOK induction and TCR engagement
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(Figure 15 A). However, in this experiment it was possible that a minor contaminating
population of GFP+ cells was selectively expanding in the presence of antibody, and that
GFP+ cells were not arising de novo from naïve GFP- precursors. To exclude this
possibility, we applied our antibody-mediated TCR stimulation assay to an immature DN
thymic lymphoma cell line, Scid.adh cells(30). Because the untransfected Scid.adh cell line
does not express any TCR heterodimer on the cell surface, we introduced the KN6 γδTCR
by transfection (95). Antibody stimulation of the KN6.Scid.adh upmodulates the activation
marker CD69 and downmodulates CD25 (Figure 14 B), as previously reported(30).
Interestingly, upmodulation of ThPOK induction showed a dose-dependent relationship
with the concentration of antibody used in these experiments (Figure 15 B and C). Because
KN6.Scid.adh cells are clonally derived, i.e. do not conatin a preexisting ThPOK+ subset,
these experiments demonstrate a direct causal relationship between TCR signal strangth
and ThPOK induction in this cell line. In an effort to delineate the signaling pathways that
control TCR-dependent ThPOK induction, we examined whether ThPOK expression was
altered in γδ thymocytes from in mice lacking the important signaling factor Id3 (Id3-/-
mice)(96). Id3 is an inhibitor of E proteins activated by TCR signaling which is known to
promote thymocyte survival and proliferation(97, 98). Previous reports from our group
proved that Id3 is an important mediator for mediating strong TCR signals and promoting
γδ development(27, 99). Significantly, RT-PCR analysis showed that ThPOK mRNA levels
were significantly reduced in mature γδ thymocytes from Id3-/- mice versus wild type (wt)
mice, indicating a potential role of Id3 in ThPOK induction in γδ thymocyte subsets (Figure
17).  The above results provide compelling evidence that ThPOK induction in DN
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thymocytes is mediated by TCR engagement and requires relatively strong stimuli. Overall
these observations argue for a common TCR-dependent mode of ThPOK induction in a
variety of T cell lineages and developmental stages. Nevertheless, there are clearly
important differences in the level of induction in different settings, i.e. both γδ thymocytes
and CD8 T cells show lower induction than class II-restricted CD4+8lo thymocytes, likely
due to differences in other transcription factors or in accessibility of the ThPOK locus
between these cell types.
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Figure 15.  ThPOK is induced in γδ thymocytes by TCR signaling.  (A) γδTCR+ GFP-
DN  thymocytes  were isolated from  DRE-GFP  mice, according to sort gate at left,
cultured for 5 days on OP9-DL1 cells in the presence or absence of anti-γδTCR and
reanalyzed by FACS for expression of GFP, γδTCR, and -NK1.1 (right-hand panels).  GFP
expression is shown for gated γδTCR+ subsets after culture.  (B) ThPOK is induced in
early thymic lymphoma cell line by TCR signaling.  Scid.adh cells transduced with the
KN6 __TCR were cultured for 24 hrs in the presence or absence of anti-γδTCR or –CD3ε
antibodies, then analyzed by FACS for expression of CD69 and CD25, and (C) ThPOK
mRNA levels assessed by real-time RT PCR (right panel). Error bars indicate SD. Results
are representative of 2 experiments.
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Figure 16.  ThPOK is induced in γδ thymocytes by TCR signaling.  (A) Analysis of
ThPOK expression by γδTCR+ DN  thymocytes from H-2d/d  or b/d mice carrying the KN6
γδTCR transgene.  Thymocytes from DRE-GFP+ mice were stained  with  anti-γδTCR, -
TCRβ, -CD24, -CD44 and –CD25, and GFP expression was assessed in the indicated
gated subsets. Red and green histograms represent equivalent gated populations from
transgenic and non-transgenic mice, respectively. (B) Levels of endogenous ThPOK
mRNA were assessed in indicated sorted γδTCR+ subsets from KN6+ mice H-2d/d  or b/d
mice (not carrying the DRE-GFP transgene) by real-time RT PCR analysis.
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Figure 17.  Id3 deficiency
impairs ThPOK induction in γδ
thymocytes. RT PCR analysis of
ThPOK expression in sorted
mature (CD24- CD44+) and
immature (CD24+ CD44-)
γδTCR+ thymocytes from Id3-/-
and wt littermate. Error bars
indicate SD of duplicate samples.
Results are representative of 2
experiments (upper panel). FACS
analysis of thymocytes from Id3-/-
and wt mice stained  with  anti-
CD4, -CD8, -γδTCR, -TCRβ, -CD24, -CD44 and –Vγ1.1. Subsets were gated as indicated
(bottom panel).
ThPOK
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4. The role of ThPOK in development and maturation of γδ thymocytes?
Given that ThPOK is expressed in γδ thymocytes, and is preferentially induced in the
mature (CD24-) fraction, it was important to determine whether ThPOK is involved in γδ
development and, if so, what its role might be. To explore this, we first utilized HD mice
(ThPOKHD/HD, or HD/HD mice), which lack functional ThPOK. Proportions of γδ
thymocytes were assessed by flow cytometry using the panel of surface markers mentioned
above. Note that HD/HD mice are congenic for the HD mutation (backcrossed for 20
generations to the C57BL/6 background), and are maintained via HD/HD x HD/+
intercrosses, in order to produce age-matched HD/HD and HD/+ littermates of a uniform
genetic background. Significantly, in HD mice, the absolute number of mature  γδ
thymocytes is substantially reduced (by 50-70%), demonstrating a key role for ThPOK in
commitment/maturation of γδ thymocytes and/or in proliferation/survival of mature γδ
thymocytes (Figure 18). Analysis of adult HD mice showed a severe (4-5 fold) reduction in
absolute numbers of NK1.1+ γδ thymocytes, but only a mild (<2-fold) reduction of CCR6+
cells. To further test the effect of ThPOK deficiency on development of thymocytes
expressing a single γδTCR specificity, we crossed KN6 mice to HD/HD and HD/+ mice on
the H-2b background (KN6 γδTCR), which has strong affinity, inducing high ThPOK
expression. Consistent with an important role for ThPOK in γδ development, the number of
mature KN6+ thymocytes and peripheral cells (marked by expression of the transgenic Vγ2
chain), was relatively high in the presence of functional ThPOK (KN6+ H-2b HD/+ mice),
but was greatly reduced in the absence of functional ThPOK (Figure 19). Thus, overall, the
results outlined above indicate that ThPOK is important for promoting the development of
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diverse subsets of γδ cells, including endogenous Vγ1.1+ and Vγ2+ subsets and KN6
gdTCR transgenic thymocytes. Given the established role of ThPOK role in CD4/CD8
lineage choice, we considered whether ThPOK might similarly control alternate
development to the NK1.1+ and CCR6+ gd subsets. Specifically, we tested whether higher
ThPOK expression might favor development of to the putatively more autoreactive NK1.1+
γδ "lineage," and whether this might occur at the expense of development to the CCR6+
lineage. To test the first point we examined whether proportions of NK1.1+ and CCR6+ γδ
subsets were altered in mice expressing a constitutive ThPOK transgene (ThPOKconst
mice), in which ThPOK expression is expressed in all T cell subsets. Of note, although the
CD4 enhancer/promoter construct is predicted to initiate transcription at the DN4/DP
transition, expression of this ThPOKconst transgene is already detected at the DN2 stage,
presumably reflecting integration site-specific regulation (data not shown). Strikingly, the
proportion of mature γδ thymocytes in ThPOKconst mice was substantially increased and
most of these cells expressed NK1.1, indicating that ThPOK in fact promotes development
and/or expansion of the NK1.1+ γδ subset (Fig. 20 A and C). To test whether expansion of
the NK1.1+ subset occurred at the expense of development to the CCR6+ fraction, we
further examined whether V region usage was altered in NK1.1+ and CCR6+ γδ subsets
from HD or ThPOKconst mice. However, no such shift in V region usage was detected
(Figure 19 A bottom panel). In particular, the CCR6+ γδ cells generated in HD mice still
uniformly utilized Vγ2, indicating that ThPOK deficiency did not result in aberrant
development of Vγ1.1+ thymocytes to the CCR6+ "lineage." Conversely, most NK1.1+
thymocytes generated in ThPOKconst mice still utilized Vγ1.1. Further, CCR6+ and
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NK1.1+ γδ subsets from HD and ThPOKconst mice showed similar preferential production
of IFN_ and IL17, respectively, as is the case in wt mice. Hence, ThPOK appears to
selectively promote development/expansion of the NK1.1+ Vγ1.1+ γδ subset, but does not
seem to control the choice between NK1.1+ and CCR6+ fates.
To assess whether ThPOK might selectively promote proliferation of NK1.1+ γδ
thymocytes, we carried out in vivo BrdU (5-Bromo-2'-deoxy-uridine) labeling of
thymocytes from wt, HD and ThPOKconst mice. In this assay the level of BrdU
incorporation into DNA, as measured by binding of fluoresecently labeled anti-BrdU
antibody, provides a measure of cell division. In a short BrdU pulse (2 hrs BrdU, followed
by 4 hrs chase) the incorporation of BrdU by γδ thymocytes was inversely correlated with
the level of maturity. In particular, immature (CD24+) gd thymocytes showed significant
incorporation, and the amount was highest at the least mature DN3 stage (Figure 24). After
a somewhat longer pulse (6 hr, and 2 hr chase), the proportion of labeled DN3 cells
decreased, while that of labeled DN4 γδTCR+ cells increased (data not shown), implying
that most BrdU incorporation in γδTCR+ thymocytes occurs at or prior to the γδTCR+ DN3
stage, and that the label moves into later stages, as these cells become mature. At short
pulse times, mature (CD24-) γδ thymocytes, regardless of strain, showed essentially no
incorporation. After 1 week of BrdU treatment, immature gd thymocytes became fully
labeled, while only 15-20% of mature γδTCR+ showed BrdU incorporation. These results
indicate that mature gd thymocytes are long-lived cells with slow turnover. Importantly,
there was no difference in BrdU incorporation for mature γδ thymocytes from HD or
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ThPOKconst mice, compared to wt controls, suggesting that proliferation of these cells is
unaffected by presence or absence of functional ThPOK (Park K, et al., EMBO J. in press).
The most likely explanation for the altered frequencies of mature γδ cells in HD and
ThPOKconst mice seems therefore to be altered homeostasis, i.e. a change either in the rate
of entry of immature precursors into this subset or in the rate of exit due to emigration or
death.
We suspect that ThPOK may, in fact, promote selection of γδ cells to the mature stage,
based on indirect evidence that ThPOK expression already correlates with γδTCR
specificity at early stages of γδ development. In adult wt animals, Vγ1.1+ cells comprise
only 15% of immature but 40% of mature γδ thymocytes, indicating significant selection
for Vγ1.1+ cells during maturation (Figure 18). In mice expressing a ThPOK-GFP reporter,
the proportion of Vγ1.1+ cells within the GFP+ (ThPOK+) fraction of γδ thymocytes
already comprises 40% at the immature γδTCR+ DN3 and DN4 stages. The increased
usage of Vγ1.1 among immature ThPOK γδ thymocytes, strongly suggests that ThPOK
expression marks cells destined for maturation to the CD24- stage, and is consistent with an
important functional role for ThPOK in the maturation process. In view of the proposition
that Vγ1.1+ cells may be enriched for self-reactive specificities (89, 99), we hypothesize
that strong TCR signals preferentially induce ThPOK in developing γδ thymocytes and that
this promotes their development to the mature NK1.1+ stage.
γδTCR+ DN Thymocytes
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Figure 18. ThPOK deficiency impairs γδthymocyte maturation. (A) FACS analysis of
γδTCR+ DN thymocytes from 1 month old HD/HD and HD/+ littermates, showing
expression of CD24, CD44, NK1.1, CCR6, Vγ1.1 and Vγ2 for indicated gated subsets. (B)
ThPOK deficiency impairs V_2+ thymocyte maturation in neonates. FACS analysis of
thymocytes from neonatal HD-/- and HD+/- littermates, showing expression of CD4, CD8,
CD24, γδTCR, and Vγ2 (left).  Ratio of mature (CD24-) versus immature (CD24+) Vγ2+
thymocytes from HD/HD and HD/+ neonatal mice (right).
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Figure 19.  Impaired development of KN6 thymocytes in HD/HD mice.  FACS analysis
of total thymocytes from KN6+ H-2b/d mice on HD/HD or HD/+ backgrounds, showing
expression of CD4, CD8, γδTCR, and CD24 (left-hand panels), or of DN thymocytes,
spleen and lymph node cells from the same mice, showing expression of TCRβ and
γδTCR.
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Figure 20. Constitutive ThPOK expression promotes __ thymocyte maturation. (A) FACS
analysis of total DN or γδTCR+ DN thymocytes from 1 month old ThPOKconst and wt
littermates stained  with  anti-γδTCR, -TCRβ, -CD24, -CD44, -NK1.1 and –CCR6. (B)
FACS analysis of γδTCR+ DN thymocytes from 6 week old ThPOKconst and wt littermates,
stained  with  anti-Vγ1.1, -NK1.1 and -CD24. (C) FACS analysis of total lymph node or
spleen cells from ThPOKconst and wt littermates stained  with anti-γδTCR, and -TCRβ.
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5. ThPOK deficiency alters peripheral γδ subset representation
We further tested in HD/HD mice whether ThPOK deficiency causes any effects on
peripheral γδ subset proportions (Figure 21 A). Comparison of splenocytes from HD/+ and
HD/HD mice revealed similar absolute numbers of γδ cells, virtually all of which express
low CD24 levels (Figure 22 A and B; data not shown). However, the distribution of γδ
subsets, as defined by expression of NK1.1 and CCR6 markers was markedly altered. In
particular, the absolute number of CCR6+ γδ cells was increased 2-3 fold in HD/HD mice,
while the number of CCR6- NK1.1- γδ cells was reduced.  Splenic CCR6+ γδ cells, like
CCR6+ γδ thymocytes, exhibit almost exclusive usage of Vγ2 on both HD/+ and HD/HD
backgrounds (Figure 22 B). It therefore seems unlikely that the increase in CCR6+ γδ
splenocytes in HD/HD mice is due to diversion of cells from the NK1.1+ or NK1.1- CCR6-
fractions, as the latter populations include much lower proportions of Vγ2+ cells. We also
examined representation of CCR6+ and NK1.1+ γδ subsets in the spleen of ThPOKconst
mice. Interestingly, the number of NK1.1+ γδ splenocytes was markedly reduced compared
to wt mice, suggesting that constitutive expression of ThPOK may inhibit
survival/expansion of these cells in the spleen (Figure 22 B). Most NK1.1+ γδ splenocytes
from wt mice are GFPlo/-, indicating that they normally downregulate ThPOK, consistent
with the possibility that continued ThPOK expression is deleterious to persistence of
NK1.1+ γδ splenocytes (Figure 21 A). Given that NK1.1+ and CCR6+ γδ subsets have
been shown to preferentially secrete IFNγ or IL17, respectively, upon stimulation (90, 100),
we assessed whether this was also the case in HD/HD and ThPOKconst mice. In both kinds
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of mice, IFNγ and IL17 production remained largely restricted to NK1.1+ and CCR6+ γδ
subsets, respectively, indicating that acquisition of these effector functions is not regulated
by ThPOK (Figure 21 B). Also, the fraction of cells expressing each cytokines, and the
levels of expression were similar to wt mice.
CD122 and CD25 have also been used to distinguish different functional γδ subsets in the
periphery, including in the peritoneal cavity (92, 101) (Figure 23). CD122 and CD25 seem
to identify similar, though not necessarily completely overlapping, γδ subsets to those
marked by NK1.1 and CCR6 expression, respectively. Thus NK1.1+ and CCR6+ γδ
thymocytes have been shown to be largely CD122+ and CD122-, respectively, and
peripheral CD122+ and CD122- (CD25+) subsets preferentially produce IFNγ and IL17A,
respectively (92, 101) similar to NK1.1+ and CCR6+ subsets. Analysis of peritoneal cavity
γδ cells in HD/HD mice, revealed that the relative proportion and absolute number of
CD122+ γδ cells was selectively reduced, paralleling the reduction in NK1.1+ γδ
thymocytes in these mice (Figure 23 B). These changes could reflect developmental or
post-developmental effects occurring in the periphery.
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Figure 21.  Effect of ThPOK deficiency on peripheral γδ T cell subsets.  (A) FACS
analysis of γ δTCR+ splenocytes, showing Vγ2 expression for indicated gated
NK1.1/CCR6 subsets. (B) Intracellular expression of IFNγ and IL17 by NK1.1+ and
CCR6+ thymus or spleen γ δ subsets, as indicated, following stimulation with
PMA/ionomycin. Thymocyte data was obtained from mature (CD24-) cells, as immature
(CD24+) cells do not produce cytokines in response to activation. HD/HD mice did not
yield sufficient mature __ thymocytes to carry out this analysis. Data for CCR6+ and
NK1.1+ subsets are shown superimposed in red and blue, respectively (percentages in red
and blue quadrants correspond to proportions of CCR6+ and NK1.1+ subpopulations,
respectively, not γδ cells as a whole). Experiments were carried out at least twice with
similar results.
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Figure 22. ThPOK deficiency impairs γδ thymocyte maturation. (A) Absolute numbers
of indicated γδTCR+ thymocyte subsets from 6 week-old HD/HD (n=4), HD/+ (n=5), and
ThPOKconst mice (n=5). Error bars indicate SD. (B) Absolute numbers of indicated γδTCR+
splenic subsets from 1 month-old HD/HD (n=4), HD/+ (n=5), and ThPOKconst mice (n=5).
E r r o r  b a r s  i n d i c a t e  S D .
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Figure 23.  ThPOK expression by peripheral γδ subsets. (A) FACS analysis of total
peritoneal cavity lymphocytes or gated γδTCR+ cells stained with anti-Thy1, -γδTCR, -
CD122 and –CD25. (B) Relative proportions of CD122+ and CD25+ peritoneal cavity γδ
cells in HD/HD versus HD+/- mice. (C) FACS analysis of GFP expression by gated
CD25+ and CD122+ γδTCR+ peritoneal cavity subsets from DRE-GFP mice on HD/HD
or HD/+ backgrounds. Green and red histograms represent equivalent gated populations
from transgenic and non-transgenic mice, respectively.
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Figure 24.  BrdU incorporation by γδ  thymocyte subsets from HD/HD, ThPOKconst
and wt mice.  FACS analysis of BrdU incorporation by indicated gated γδ thymocyte
subsets from mice treated with BrdU for indicated time periods.
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IV. DISCUSSION
During αβ T cell development cells diverge into alternate CD4 helper and CD8+ cytotoxic
T cell lineages.  The precise correlation between a T cell’s CD8 and CD4 choice and its
TCR specificity to class I or II MHC was noted more than 20 years ago, and establishing
the underlying mechanism has remained a focus of intense study since then. It is widely
accepted that TCR signaling exerts a decisive influence on lineage choice, although the
underlying mechanism remains intensely debated.  Different models postulate either an
instructive or selective effect of TCR signaling on lineage choice, suggest that lineage is
determined either by differing strength or duration of TCR signaling, and alternately
postulate that lineage fate is decided by TCR signals received at the DP or CD4+8lo stages.
Current evidence suggests that the mechanism of lineage choice may correspond most
closely to a combination of the kinetic signaling and quantitative instructive models.
Alternate expression of the CD4 and CD8 genes is the most visible manifestation of lineage
choice and so has been closely studied with the aim of elucidating the responsible upstream
signaling pathways. The identification of spontaneous mutant HD mice, which show a
specific defect in CD4/CD8 lineage commitment, but not in thymocyte positive selection,
represented an important breakthrough in defining the underlying molecular pathways for
this process. Interestingly, HD mice fail to produce mature CD4+ T cells, and instead show
redirection of all MHC class-II restricted thymocytes to the CD8 lineage (36). The specific
basis for the HD defect was mapped to a point mutation in the gene encoding the
transcription factor ThPOK. ThPOK is selectively expressed in class II-restricted cells at
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the CD4+8lo stage and acts as a “master regulator” of lineage choice, as its expression is
both necessary and sufficient for development of immature thymocytes to the CD4 lineage.
Given the central role of ThPOK in lineage commitment, understanding its upstream
regulation and downstream gene targets should reveal further important aspects of the
molecular machinery underlying lineage commitment. My current studies on transcriptional
regulation of ThPOK have contributed to understanding how ThPOK expression is
controlled during development and what upstream factors may be involved. In addition,
these studies show that ThPOK plays a broader role in T cell development than initially
recognized, in particular in promoting maturation of the γδ T cell lineage.
(1) How is ThPOK regulated at the level of transcription?
There is a tight correlation between ThPOK protein and mRNA expression in thymocytes,
indicating that the main method of controlling ThPOK during development is at the level of
transcription [27, 89].  Consequently, elucidating the transcriptional regulation of ThPOK
should eventually lead to identification of upstream pathways that control lineage choice, a
so-called "bottoms-up" approach. BAC transgene complementation of ThPOKHD/HD mice
demonstrated that normal regulation of lineage commitment could be achieved by a 20 kb
genomic fragment extending from 17 kb upstream to 500 bp downstream of the ThPOK
coding exons.  Specifically, this fragment restored development of class II-restricted
thymocytes to the CD4 lineage, without perturbing development of class I-restricted cells to
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the CD8 lineage, demonstrating that it contains all elements required for normal regulation
of ThPOK expression [42].
The ThPOK locus contains two promoters, located 6kb apart and conserved between
human and mouse (81, 102).  Although transcripts produced from these promoters differ in
their first non-coding exons, they nevertheless encode the same protein product, as the first
in-frame start codon is located within a common downstream exon.  Both promoters are
utilized in thymocytes, but exhibit distinct developmental expression patterns, with the
distal promoter preferentially active earlier at the CD4+8lo stage.  Comparison of ThPOK
genes from different species reveals striking conservation of non-coding sequences near the
ThPOK gene, consistent with the presence of important regulatory elements.  Our analysis
of DNAse hypersensitive (DHS) sites, which often mark regulatory elements associated
with DNA binding factors, identified six discrete sites or clusters of sites within the
minimal functional 20kb ThPOK gene.  Two of these DHS sites coincide with the distal
and proximal promoters, while we have shown that the others represent enhancers or
silencers.  In particular we have shown a crucial role for the distal regulatory element
(DRE), as a lineage specific silencer.  Thus, deletion of the ThPOK silencer in mice, results
in derepression of ThPOK in class I restricted cells and severe reduction of CD8 T cells,
indicating an essential physiological role for this element in lineage-specific transcriptional
control of ThPOK (81, 102).  We further showed that the DRE also encodes enhancer
activity when linked to a heterologous minimal promoter. Reporter constructs containing
the DRE element in the context of the distal promoter show highest expression in CD4+8lo
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cells, when lineage is probably determined, suggesting that regulation of DRE function is
critical for lineage commitment.  It remains to be established whether enhancer and silencer
functions of the DRE are encoded by overlapping or separable regions of the DRE.  The
500bp ThPOK silencer contains a number of transcription factor consensus sites with
potential relevance to lineage commitment, in particular two consensus Runx sites.
However, the precise importance of these sites for lineage-specific ThPOK expression is
somewhat unclear.  In one study, mutation of both Runx sites led to partial derepression of
a reporter transgene in the CD8 lineage (81, 102), while deletion of both sites in another
study did not significantly impair repression in CD8 cells (81, 102).  This discrepancy may
reflect differences in transgene copy number and/or integration site. Of note, even in the
former study the proportion of GFP+ cells was much lower in CD8 than in CD4 cells,
indicating that Runx factors cannot be the only regulators of DRE-mediated silencing
activity.
The observation that the ThPOK silencer is necessary to suppress ThPOK expression in the
CD8 lineage, implies that the ThPOK locus encodes another cis element with promiscuous
enhancer activity.  This could be the enhancer activity encoded by the DRE element or
another enhancer located elsewhere. Indeed, further reporter gene assays identified a strong
enhancer near DHS site C (located downstream of the distal promoter), which exhibits
activity in both CD4 and CD8 lineages (referred to as the "general T lymphoid element" or
GTE) (81, 102).  Deletion of DHS site C, within the context of a 6kb reporter construct that
lacks the DRE, abolishes this promiscuous expression, indicating that this region is
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necessary for GTE activity, although additional downstream regions may be required.
Importantly, inserting the DRE into a reporter construct containing an intact GTE element
restricts reporter expression to the CD4 lineage, directly demonstrating that the DRE
silencer controls GTE activity.  A distinct CD4 lineage-specific enhancer maps near DHS
site E (1kb downstream of the proximal promoter), which is referred to as the "proximal
regulatory element" (PRE) or "proximal enhancer" (PE) (81, 88, 102).  The PRE is
incapable of suppressing activity of the GTE in the CD8 lineage, and thus seems to function
only as an enhancer and not as a silencer (81, 102).  Further, it appears to function
predominantly late in development, as reporter transgenes controlled exclusively by the
PRE show highest expression in peripheral CD4 T cells, and targeted deletion of the PRE
causes a severe 20-fold reduction in ThPOK expression in peripheral CD4 T cells (but only
a 5-fold reduction in SP CD4 thymocytes) (81, 88, 102).  Importantly, targeted deletion of
the PRE element causes only a mild decrease in the generation of SP CD4 thymocytes,
suggesting that it does not play a major role in CD4 lineage commitment (81, 88, 102).
Taken together these results support a model in which the DRE silencer functions as the
primary regulator of ThPOK induction in class I- versus II-restricted CD4+8lo thymocytes,
and thus is the most likely target of TCR-dependent signaling factors that determine lineage
choice. We suggest that the DRE acts as a constitutive silencer, unless bound by factors
induced/activated by strong TCR signals. When DRE silencer activity is overcome by these
factors, the DRE- and GTE-encoded enhancers drive ThPOK transcription leading to CD4
commitment.  It remains to be established which one of these enhancers plays the
predominant role in this process, or whether both are essential.
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(2) The role of ThPOK in γδ Lineage Development
As mentioned above, the transcription factor ThPOK was identified as a "master regulator"
of CD4/CD8 commitment, that is necessary and sufficient for CD4 development(78, 82,
103). It was further revealed that ThPOK initiates selectively in class II-restricted
thymocytes at the intermediate CD4+CD8lo stage αβ T cell development. Initially, it was
assumed that this was the only stage in thymci developemnt when ThPOK was expressed,
as a consequence of strong TCR signaling (85). Recent studies indicate that TCR signal
strength also plays an important  role at an in earlier stage in thymic development, i.e. at the
DN stage during divergence of the ab and gd lineages. Specifically, it has been postulated
that strong TCR signals promote γδTCR lineage commitment, whereas relatively weak
TCR signals promote αβ lineage thymocyte development (27, 99). Nevertheless, this
hypothesis remains strongly debated, and the downstream mediator of γδTCR signaling that
promotes γδ commitment has not been identified. We postulated that ThPOK might be a
key downstream mediator of TCR mediated signaling during γδ lineage commitment and/or
γδ maturation. We designed and executed a series of experiments that validate this
hypothesis. Although ThPOK is therefore important for gd maturation the precise
molecular basis for this role remains to be elucidated.
In order to assess possible functions of ThPOK in other T cell subsets, it was important to
develop GFP reporter mice which would accurately track ThPOK expression throughout
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thymc development at the single cell level. For this purpose, we used 2 lines of mice that
were originally generated for the mapping of of ThPOK transcriptional control elements.
We focussed on 2 kinds of reporter mice: 1) ThPOK-GFP mice in which GFP expression is
controlled by the complete ThPOK locus, comtaing all identified cis elements, and 2) DRE-
GFP mice in which GFP expression is controlled by the distal regulatory element (DRE)
alone. In both models, we found that reporter expression was substantially induced in
γδTCR+ DN thymocytes, and that GFP expression closely matched expression of
endogenous ThPOK. Reporter expression in gd thymocytes is substantial (100-fold above
background for the brightest cells) and highly consistent between different founder strains
and between individual animals, regardless of age. The fact that DREGFP mice showed
similar reporter expression to ThPOKGFP mice indicates that the DRE element is sufficient
to mediate stage-specific expression in the gd lineage.
Our studies of ThPOK expression in the γδ lineage provide compelling evidence that strong
TCR signals are a key inducer of ThPOK in T cells. This is demonstrated in multiple
different ways: 1) ThPOK+ γδ thymocytes predominantly exhibit an activated (CD44+)
phenotype, consistent with prior TCR stimulation by intrathymic ligands. 2) Transgenic
mice expressing the KN6 γδTCR, which recognizes nonclassical MHC class Ib ligands,
T10b and T10d [50-52], with relatively high and low affinity, respectively [53], show
differential ThPOK induction.  In particular, there is much higher ThPOK expression on the
high affinity H 2b background, as assessed by both FACS and RT-PCR assays. 3) ThPOK-
dependent reporter expression could be directly induced in vitro by strong antibody-
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mediated TCR stimulation of primary immature γδ thymocytes, and 4) An immature
thymocyte cell line model shows dose-dependent induction of ThPOK in response to anti-
TCR antibody stimulation (KN6 Scid.adh). Overall these results show a clear causal
relationship between strong TCR engagement and ThPOK induction.
In light of our evidence that ThPOK is induced in response to strong TCR signals, it may
seem counter-intuitive that ThPOK is still expressed by γδ thymocytes from Id3-/- mice,
even though Id3 deficiency severely impairs development of KN6 thymocytes and DETC
γδ cells(99).  Significantly, mature γδ thymocytes from Id3-/- mice almost all express the
Vγ1.1 segment. The same phenomenon occurs in CD3δ-/-mice in which TCR signaling is
impaired by diminishing TCR surface expression (unpublished data). We suspect that
preferential development of Vγ1.1+ cells in these situations reflects a selective advantage
for strongly self-reactive specificities, which appear to be disproportionately represented
within the Vγ1.1+  fraction.  High affinity γδTCRs could compensate for downstream
signaling deficiencies, for instance, by sustaining longer signals, and thus still promote
ThPOK induction.  Although no self-ligands for Vγ1.1+ cells have yet been identified,
there is circumstantial evidence that cellular selection controls their development (104).
Furthermore, many Vγ1.1 thymocytes exhibit an activated CD44+ NK1.1+ phenotype,
resembling γδ NKT cells which are well-known to be selected by thymic self antigens
(Kronenberg & Engel, 2007).  Hence, one might speculate that Vγ1.1+ cells developing on
a signaling deficient background are particularly high affinity cells, perhaps including cells
that would normally undergo negative selection.
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ThPOK expression in the gd lineage is stage-dependent, such that mmature (CD24+) gd
thymocytes show relatively low expression by a minority of cells, while mature (CD24-) gd
thymocytes show high expression by most cells. We postulate that immature ThPOKlo gd
thymocytes are direct precursors of mature ThPOKhi cells. Consistent with this view
immature ThPOKlo cells show a smilar enrichment for Vg1.1 usage as is seen in mature gd
thymocytes. Mature CD24- cells split into distinct GFPmed and GFPhi fraction, which
correlate to a major extent with the distinct CCR6+ and NK1.1+ gd subsets. We tentatively
propose the following maturation sequence for γδ thymocytes based on GFPThPOK
reporter expression: CD24+ CD44- GFP- > CD24+ CD44- GFPlo > CD24- CD44+
GFPmed / CD24- CD44+ GFPhi.  NK1.1+ γδTCR+ cells appear to represent a separate
lineage, termed NKTγδ cells, marked by a distinct V region repertoire, in particular high
usage of Vγ1.1 [48].  Consistent with expectation, GFP+ NK1.1+ γδTCR+ cells are
enriched for Vγ1.1 usage (data not shown).  The induction of ThPOK during the CD24+ to
CD24- transition of γδ development suggests the hypothesis that ThPOK expression is
induced by signals that drive γδ commitment or selection, and that ThPOK expression may
be a useful marker of these processes. Because of the recently demonstrated role of the
transcription factor Plzf in γδ development [49], we have also tested whether GFP+ γδ
subsets from GFPThPOK mice express Plzf .  Indeed, real-time RT PCR analysis of sorted
thymocyte subsets showed that Plzf was induced not only in NKTγδ cells, but in all GFP+
γδ subsets (data not shown).  In contrast to ThPOK, Plzf expression peaks at the CD44+
GFPhi rather than GFPmed stage.  We conclude that ThPOK is preferentially expressed in
γδ thymocytes bearing mature and activated phenotypes, in particular in NKTγδ cells, and
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that its expression pattern significantly overlaps with that of Plzf.  Like ThPOK, Plzf
belongs to the POK family of transcription factors and is a known regulator of lineage
choice.  It remains t be determined whether ThPOK and Plzf play redundant or distinct
roles in regulating γδ and/or NKTγδ selection and maturation.
Finally, our results demonstrate an important role for ThPOK in γδ development, as
assessed by changes in γδ thymocyte proportions and surface marker expression in mice
expressing non-functional ThPOK (HD/HD mice). Although the total % of γδ thymocytes
is similar in HD/HD and HD/+ mice (data not shown), the proportion of mature (CD24-) γδ
thymocytes is markedly reduced, particularly of the NKTγδ subset (three-fold reduction of
total CD24- thymocytes, and five-eight fold reduction in NKTγδ cells).  Furthermore, the
proportion of mature (CD24-) Vγ1.1+ cells is substantially reduced relative to the
proportion of mature Vγ2+ cells, consistent with a preferential defect in NKTgd
development.  The relative proportions of Vγ1.1+ and Vγ2+ cells are already shifted at the
immature CD24+ γδTCR+ DN4 stage (10:1 in HD/HD versus 5:1 in HD/+ mice),
indicating that ThPOK regulates γδ development before the CD24+ DN4 to CD24- DN4
transition. Lending further support for a role of ThPOK in γδ maturation, constitutive
ThPOK expression leads to a three-five fold increase in the proportion of mature (CD24-
CD44+) thymocytes and a nine-fold increase in Vγ1.1+ NK1.1+ thymocytes.  Interestingly,
there is also a relative increase in the proportion of γδTCR- DN4 cells in these mice (they
are more abundant than γδTCR- DN3 cells, while the opposite is true in wt littermates),
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which might suggest redirection of preTCR-expressing thymocytes to the γδ lineage (data
not shown).  In view of the significant effects of ThPOK deficiency and ThPOK
overexpression on γδ and NKTγδ cell proportions, we conclude that ThPOK is, in fact, a
key regulator of development, and /or survival.  Importantly, BrdU experiments indicate
that ThPOK does not regulate proliferation of mature gd thymocytes. Althouth ThPOK is
clearly important for development of most mature gd thymocytes, it cannot be the only
mediator of γδ thymocytes development, since a significant number of mature cells still
develop in the absence of functional ThPOK. Similarly, in mice expressing the KN6 gd
TCR trasngene in the presence of the low affinity T10d ligand, a significant number of
mature gd thymocytes arise, although there is a little if any ThPOK induction. In this
context, it is interesting that a related  POK family factor, Plzf, was recently reported to be
expressed in γδ thymocytes, particularly in Vγ1.1+ thymocytes (93). It is therefore possible
that there is functional redundancy between these two factors with respect to gd
development.
110
V. Materials and Methods
Mice
AND transgenic mice are HMC class-II restricted TCR and promote DP thymocytes to
CD4+ lineage and OT-1-TCR (Hogquist et al., 1994) transgenic is conversely against MHC
class-I restricted TCR generating only CD8+ lineage T cells. CD3δ-/- mice is lack of CD3δ
subunit of TCR/CD3 complex and block αβTCR signaling which is required for normal
αβTCR development. Consequently, thymocytes are arrested on DP stage by interrupting
DP to SP transition. MHC Iab-/- and MHC β2M-/- mice are MHC class-II deficient and
MHC class-I deficient, respectively.  Helper Deficient (HD) mice are well described in this
paper. All other transgenic lines, including GFP reporter and ThPOK Tg+ transgenic mice
used here were generated by the FCCC Transgenic Facility. Animal care was in accordance
with National Institutes of Health (NIH) guidelines.
Flow Cytometry and Cell Sorting
Cells were prepared from thymus and peripheral blood and analyzed by flow
cytometry according to standard procedures. Briefly, for peripheral blood lymphocytes
(PBL) analysis, whole blood is obtained from orbital sinus of mice in a collection tubes
containing 0.25U/ml of heparin. Lympholyte M (Cedar Lane) is slowly added on the
bottome of the tube to layer under the cell suspension. Because Lympholyte M is much
denser than cell suspension, the cell suspension will form a layer above the Lympholyte M.
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After centrifugation, there will be well-visible lymphocytes at the interface. Staining for
FACScan or sort used 0.25 µg in 106 cells in 100 µl.
All antibodies used for CD4(GK1.5), CD8a, CD25, CD44, CD24(HSA), TCRβ(H57),
γδTCR(GL3), NK1.1, Thy1.2, anti-Vγ1, anti-Vγ3, BrdU were purchased from BD,
eBioscience, or BioLegend and used as biotin, FITC, phycoerythrin(PE), PE-Cy5, PE-Cy7,
allophycocyanin(APC), APC-Cy7, Pacific Blue, Qdot(605), and peridinin chlorophyll
protein(PerCP)-Cy5.5 conjugates. Fluorochrom-conjugated streptavidin was used to reveal
staining with biotinylated monoclonal antibody (mAb). Flowcytometry and cell sorting was
performed using FACScan(BD) and FACS Diva (BD). Data were analyzed with FlowJo
software (TreeStar). Frequencies of some cell populations are mentioned in the text as
mean±SD.
For enrichment of DN subset, cells were isolated, separated by MACS (Miltenyi Biotech)
and labeled with CD4 and CD8 conjugated magnetic beads (Miltenyi Biotech). Thymocytes
are then enriched negatively on MACS cell separator (Miltenyi Biotech) twice to exclude
all other possible DP and SP thymocytes. Depleted DN thymocytes were washed and
performed Lympholyte M (CedarLane) to obtain live thymocytes for culture. After 3-7days
culture in CO2 incubator, thymocytes are collected for stains to determine differentiation by
labeling with propodium iodine (PI).
In vivo TCR Stimulation Assay
For in vivo a-TCR stimulation, young adult IAb mice were injected intraperitoneally with
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30 mg of anti-TCRβ antibody (H57) per 1 g of body weight. Thymocytes were isolated and
labeled with appropriate antibodies for quantitative detection of mRNA expression.
In Vitro TCR Stimulation
For in vitro stimulation, 105 sorted thymocytes were cultured in DMEM with 10% FSC on
96-well plates precoated with 20 mg/ml each of anti-CD3ε (2C11) and anti-CD28.
SCID.ADH cells, which are arrested on DN stage, were cultured in Iscove’s MEM with
regular additives and transfected with KN6 receptor (generously provided by Dr. D. Wiest).
Cells were collected in different time points, and RNA were obtained by phnol/chloroform
extraction for Real-Time PCR to measure mRNA level of ThPOK expression.
Quantitative Real-Time PCR
Real-time RT PCR analysis for Th-POK and EGFP was carried out according to the probe-
based method and analyzed by the comparative Ct method (compared to b-actin). Primer
and probe sequences are provided in the following.
PCR assays for detection of alternate distal and proximal ThPOK transcripts employed
forward primers specific to the distal or proximal noncoding exons in combination with a
common reverse primer located at the beginning of the first coding exon.
Distal noncoding exon, forward primer:        5’-ACCCAACGGCTGAAAGGA-3’
Proximal noncoding exon forward primer:    5’-CCTCAGCGTTCAGGAGAAGAT-3’
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Common first coding exon reverse primer:   5’-GCTGCTGTGGTCTGGCAAT-3’
DNase I Hypersensitivity (DHS) Analysis
Heterochromatin is a transcriptionally inactive DNA, which is tightly packaged into
condensed chromatin such that it is unavailable to the transcription initiation complex.
Activation of the silenced genes during processes such as differentiation first requires that
the chromatin structure be remodeled into a transcriptionally permissive configuration, with
the DNA “exposed” and accessible to transcription factors. The change to chromatin
structure, called euchromatin provide open structure that transcription factors can bind to
activation sitse of DNA. This can be detected as increased sensitivity of the exposed DNA
to digestion with DnaseI enzyme. This increased susceptibility is referred to as DnaseI-
hypersensitivity. DNaseI hypersensitive sites are often located in the recognition sites for
transcription factors, including promoters, enhancers, silencers or other regulatory
elements. DNaseI hypersensitivity assay is a technique understanding of the chromatin
remodeling processes and identifying DNA sequences (cis-elements) that putative
transcription factors bind.
DHS analysis was carried out according to standard procedures. In brief, 107–108 primary
thymocytes were allowed to swell in ice-cold high-salt buffer (10 mM Tris pH 7.4, 100 mM
NaCl, 30 mM MgCl2, 0.1% NP-40) for 15 min, and nuclei were isolated by centrifugation.
The nuclear pellet was then resuspended in low-salt buffer (10 mM Tris pH 7.4, 10 mM
NaCl, 3 mM MgCl2, 0.1% NP-40 buffer), divided into 120 ml aliquots, and briefly treated
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with varying concentrations of DNase I (Worthington: DPRF). DNase I digestion was
stopped by addition of an equal volume of cell lysis buffer and DNA was isolated with
Genomic DNA purification kit (Puregene). Southern blotting was carried out according to
standard procedures with different probes, as indicated in Figure.
Probes for DHS site analysis were chosen based on their lack of repetitive sequences,
predicted specificity based on blast analysis of the mouse genome, and location near useful
restriction sites. Probes were amplified by PCR, subcloned, and confirmed by DNA
sequencing. Locations of probes are given below with reference to a mouse BAC, rp23-
368d24, that contains the entire ThPOK locus (numbering according to the AC104632
sequence file accessioned in Genbank).
Probe 7b:   22,643–23,123
Probe 9:     13,084–13,589
Probe 10:     9,149–9,540
Probe 12b: 27,808–25,233
Probe 13:   20,927–21,400
Preparation of Nuclear Extracts
Nuclear proteins were extracted from 1x 108 thymocytes. Briefly, cells were washed with
PBS and gently lysed in sucrose buffer containing 0.1% Nonidet P-40 while the nuclei
remain intact. After a washing step, the crude nuclei are suspended in a hypotonic ‘low salt
buffer’ to swell the nuclei. After 20 minutes incubation on ice, the nuclei is pipette to
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dounce homogenizer to break nuclei. Then a ‘high salt buffer’ is added slowly,
nucleoplasm is extracted into the buffer while the nuclear envelop stays intact and retains
the genomic DNAs. The mixture vigorously disturbed in the shaker on ice for an hour. The
extract is separated from the nuclear envelop/DNA by centrifugation. The suspension
containing crude nuclear extracts are dialysed to remove an extra remaining sodium in
dialysis buffer at 4 °C for overnight. The purified nuclear extract keep in –70 °C freezer
until uses. To obtain the best results, we slightly changed standard binding reaction in
buffers and binding conditions described later in Methods and Materials.
Electromobility Shift Assay (EMSA)
• EMSA
For the EMSA, nuclear extracts are incubated with a radioactive labeled oligonucleotide
probe which contains the specific recognition sequence for NF-kB here as either control or
detection. The binding reaction occurs under specific salt/pH conditions in a binding buffer.
Poly-dIdC is added to prevent non-specific binding of proteins to the oligonucleotide probe
used and by this to reduce background. After binding, the samples are separated on a non-
denaturating 6% polyacrylamide (PAGE) gel containing 1X Tris-borate-EDTA. Gel were
run at 100V for 4h, dried, and visualized by autoradiography. Radioactivity on the
membrane was quantified with a BAS-2000 bioimaging analyzer (Fuji, Japan). The
intensity of the shifted band is a measure for the amount of the transcription factor in the
nuclear fraction. To check if the observed shifted bands are specific, competition tests, a
nonlabeled ‘cold’ oligonucleotide is added in excess, are run to a protein extract. Cold
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competition oligonucleotides are used that either contain the wildtype recognition site or a
slightly mutated site.
• Supershift
In order to determine specific binding of trans-acting factors, potential antibodies were
added prior to radioactive probe were added to the mixuture. The antibodies will bind to the
corresponding potential subunit as forming what results in a trans-acting
factor/probe/antibody tertiary complex, so that a supershifted band can be observed.
• Probes for EMSA
The following oligonucleotides annealed to complementary strands, resulting in double-
stranded probes. The quantitated probes were 32P labeled with T4 Kinase (Invitrogen).
NF-κB 5’-ACCAAGAGGGATTTCACCTAAATC-3’
Sp1 5’-GCGATCGGGGCGGGGCGATC-3’
B1 5’-GGGTAGTCGGCGGGAGGGGGTACCCTTGGCAG-3’
Mutant B1 5’-GGGTAGTCGGCGGGAGGAAGTACAATTGGCAG-3’
RB1 5’-GCGGGAGGGGGTACCCTTGGC-3’
LB1 5’-GGGTAGTCGGCGGGAGGGGGC-3’
• Antibodies for EMSA
Rabbit anti-p50 and anti-Sp1 were purchased from Millipore.
OP9-DL1 Coculture System
OP9 bone marrow stromal cells expressing the Notch ligand DL1 (OP9-DL1) were cultured
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as a monolayer in OP9 media (αMEM supplemented with 20% FCS[HyClone} and 2.2 g/L
sodium bicarbonate). OP9-DL1 cells were plated at 2x104 cells/well in 24 well plate. Sorted
γδ thymocytes from MACS enriched DN thymocytes were plated onto the OP9-DL1
monolayers, then harvested 3 days later, and analyzed by FACScan. All cocultures were
performed in the presence of 1 ng/ml IL-7 and 5 ng/ml of Flt3 ligand.
Pulsed BrdU Incorporation
For cell proliferation turnover, we injected BrdU (Sigma) intraperitoneally at a dose of
5mg/ml over either 6 hour (2 hours apart) or 7 days (12 hours apart) and analyzed in 6, 12,
and 24 hours after final injection. After BrdU treatment, cells are stained with appropriate
surface markers, fixed and permeablized, treated in DNase I and labeled with anti-BrdU
provided by Cytofix/Cytoperm BrdU Labeling Kit (BD).
Intracellular Staining
Thymocytes were isolated and stained with surface markers as describes above. After
resuspend, cells are fixed and permeabilized for 20 min at 4 °C by using BD
cytofix/cytoperm kit. A pre-determined optimal concentration of a fluorochrome-
conjugated anti-Plzf antibody (provided by co-worker) was added into and incubated for 30
minutes at 4 °C, and cells were analyzed by flow cytometer.
Preparation of Epithermal cells (DETC, Dendritic Epithermal T-cell)
118
Mice were shaved hair from neck to base of tail using hair remover or surgical blades.
Mouse ventral and dorsal skin avoiding subcutaneous fatty tissue is carefully removed
using scissors and forceps and placed on a Petri dish, which was rinsed and wiped with an
alcohol and allowed to dry, containing 10 ml of trypsin (Sigma, T1005) GNK solution (1.0
mM Glucose, 0.4 KCl, 8.6 mM NaCl, then balanced pH7.6 with NaHCO3). Skins were
placed dermal side up and incubate at 4 °C overnight. Next day, all epidermis from dermis
are removed mechanically by using forceps and placed in trypsin-GNK containing 0.1%
DNaseI (ICN). Cells were pelleted down in Iscove’s DMEM media (10% FCS and 0.1%
DNaseI), resuspended and cultured overnight at 37 °C in CO2 incubator in the media. Cells
were collected and stained for analysis of flow cytometer.
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